School of Medicine

Publications for Christopher Griffiths

2013

  • Ali, F., Barton, A., Smith, R., Bowes, J., Flynn, E., Mangino, M., Bataille, V., Foerster, J., Worthington, J., Griffiths, C. & Warren, R (2013). An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene. Br J Dermatol, 168(4), 864-6. eScholarID:198825 | PMID:23106574 | DOI:10.1111/bjd.12106
  • Bundy, C., Pinder, B., Bucci, S., Reeves, D., Griffiths, C. & Tarrier, N (2013). A Novel, Web-Based, Psychological Intervention for People with Psoriasis: The Electronic Targeted Intervention for Psoriasis (eTIPs) Study. Br J Dermatol, eScholarID:198823 | PMID:23551271 | DOI:10.1111/bjd.12350
  • Chularojanamontri, L. & Griffiths, C (2013). Biologic therapies in dermatology. Br J Hosp Med (Lond), 74(1), 12-7. eScholarID:198824 | PMID:23593668
  • Ennis, H., Herrick, A., Cassidy, C., Griffiths, C. & Richards, H (2013). A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases. Clin Exp Rheumatol, eScholarID:198820 | PMID:23324653
  • Gunn, D., de Craen, A., Dick, J., Tomlin, C., van Heemst, D., Catt, S., Griffiths, T., Ogden, S., Maier, A., Murray, P., Griffiths, C., Slagboom, P. & Westendorp, R (2013). Facial appearance reflects human familial longevity and cardiovascular disease risk in healthy individuals. J Gerontol A Biol Sci Med Sci, 68(2), 145-52. eScholarID:198872 | PMID:22879455 | DOI:10.1093/gerona/gls154
  • Langan, E., Lisztes, E., Bíró, T., Funk, W., Kloepper, J., Griffiths, C. & Paus, R (2013). Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro. Br J Dermatol, 168(3), 520-5. eScholarID:198865 | PMID:23176199 | DOI:10.1111/bjd.12113
  • Langan, E., Vidali, S., Pigat, N., Funk, W., Lisztes, E., Bíró, T., Goffin, V., Griffiths, C. & Paus, R (2013). Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin. PLoS One, 8(4), e60819. eScholarID:198889 | PMID:23626671 | DOI:10.1371/journal.pone.0060819
  • Langton, A., Griffiths, C., Sherratt, M. & Watson, R (2013). Cross-linking of structural proteins in ageing skin: an in situ assay for the detection of amine oxidase activity. Biogerontology, 14(1), 89-97. eScholarID:198861 | PMID:22923173 | DOI:10.1007/s10522-012-9394-3
  • Mrowietz, U., Kragballe, K., Reich, K., Griffiths, C., Gu, Y., Wang, Y. & Rozzo, S (2013). An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals. Br J Dermatol, 168(2), 374-80. eScholarID:198822 | PMID:22880843 | DOI:10.1111/j.1365-2133.2012.11214.x
  • Nelson, P., Chew-Graham, C., Griffiths, C., Cordingley, L. & . (2013). Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol, 168(2), 354-61. eScholarID:198882 | PMID:22880951 | DOI:10.1111/j.1365-2133.2012.11217.x
  • Noordam, R., Gunn, D., Tomlin, C., Maier, A., Griffiths, T., Catt, S., Ogden, S., Slagboom, P., Westendorp, R., Griffiths, C., van Heemst, D., de Craen, A. & . (2013). Serum insulin-like growth factor 1 and facial ageing: high levels associate with reduced skin wrinkling in a cross-sectional study. Br J Dermatol, 168(3), 533-8. eScholarID:198887 | PMID:23363376 | DOI:10.1111/bjd.12131
  • Papp, K., Griffiths, C., Gordon, K., Lebwohl, M., Szapary, P., Wasfi, Y., Chan, D., Hsu, M., Ho, V., Ghislain, P., Strober, B., Reich, K., , , , & . (2013). Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol, 168(4), 844-54. eScholarID:198875 | PMID:23301632 | DOI:10.1111/bjd.12214
  • Parisi, R., Symmons, D., Griffiths, C., Ashcroft, D. & . (2013). Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol, 133(2), 377-85. eScholarID:198870 | PMID:23014338 | DOI:10.1038/jid.2012.339
  • Roberts, J., Warren, R., Griffiths, C. & Ross, K (2013). Expression of microRNA-184 in keratinocytes represses argonaute 2. J Cell Physiol, eScholarID:198864 | PMID:23696368 | DOI:10.1002/jcp.24401
  • Sathish, J., Sethu, S., Bielsky, M., de Haan, L., French, N., Govindappa, K., Green, J., Griffiths, C., Holgate, S., Jones, D., Kimber, I., Moggs, J., Naisbitt, D., Pirmohamed, M., Reichmann, G., Sims, J., Subramanyam, M., Todd, M., Van Der Laan, J., Weaver, R. & Park, B (2013). Challenges and approaches for the development of safer immunomodulatory biologics. Nat Rev Drug Discov, 12(4), 306-24. eScholarID:198862 | PMID:23535934 | DOI:10.1038/nrd3974
  • Thorneloe, R., Bundy, C., Griffiths, C., Ashcroft, D. & Cordingley, L (2013). Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol, 168(1), 20-31. eScholarID:198821 | PMID:22963128 | DOI:10.1111/bjd.12039
  • Tran, C., Michelet, J., Simonetti, L., Fiat, F., Garrigues, A., Potter, A., Segot, E., Watson, R., Griffiths, C. & de Lacharrière, O (2013). In vitro and in vivo studies with tetra-hydro-jasmonic acid (LR2412) reveal its potential to correct signs of skin ageing. J Eur Acad Dermatol Venereol, eScholarID:198874 | PMID:23701744 | DOI:10.1111/jdv.12113

2012

  • Ali, F. & Griffiths, C (2012). So you want to be a clinical academic. Br J Hosp Med (Lond), 73(2), C23-5. eScholarID:180718 | PMID:22504711
  • Ali, F. & Griffiths, C (2012). So you want to be a clinical academic. Br J Hosp Med (Lond), 73(2), C23-5. eScholarID:198888 | PMID:22504711
  • Ali, F., Barton, A., Smith, R., Bowes, J., Flynn, E., Mangino, M., Bataille, V., Foerster, J., Worthington, J., Griffiths, C. & Warren, R (2012). An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene. Br J Dermatol, eScholarID:180701 | PMID:23106574 | DOI:10.1111/bjd.12106
  • Burden, A., Warren, R., Kleyn, C., McElhone, K., Smith, C., Reynolds, N., Ormerod, A., Griffiths, C. & . (2012). The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives. Br J Dermatol, 166(3), 545-54. eScholarID:180719 | PMID:22356636 | DOI:10.1111/j.1365-2133.2012.10835.x
  • Burden, A., Warren, R., Kleyn, C., McElhone, K., Smith, C., Reynolds, N., Ormerod, A., Griffiths, C. & . (2012). The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives. Br J Dermatol, 166(3), 545-54. eScholarID:198886 | PMID:22356636 | DOI:10.1111/j.1365-2133.2012.10835.x
  • Chiang, Y., Tosti, A., Chaudhry, I., Lyne, L., Farjo, B., Farjo, N., Cadore de Farias, D., Griffiths, C., Paus, R. & Harries, M (2012). Lichen planopilaris following hair transplantation and face-lift surgery. Br J Dermatol, 166(3), 666-370. eScholarID:180712 | PMID:21985326 | DOI:10.1111/j.1365-2133.2011.10692.x
  • Chiang, Y., Tosti, A., Chaudhry, I., Lyne, L., Farjo, B., Farjo, N., Cadore de Farias, D., Griffiths, C., Paus, R. & Harries, M (2012). Lichen planopilaris following hair transplantation and face-lift surgery. Br J Dermatol, 166(3), 666-370. eScholarID:198876 | PMID:21985326 | DOI:10.1111/j.1365-2133.2011.10692.x
  • Crawshaw, A., Griffiths, C. & Young, H (2012). Investigational VEGF antagonists for psoriasis. Expert Opin Investig Drugs, 21(1), 33-43. eScholarID:180714 | PMID:22088218 | DOI:10.1517/13543784.2012.636351
  • Crawshaw, A., Griffiths, C. & Young, H (2012). Investigational VEGF antagonists for psoriasis. Expert Opin Investig Drugs, 21(1), 33-43. eScholarID:198877 | PMID:22088218 | DOI:10.1517/13543784.2012.636351
  • Fordham, B., Griffiths, C. & Bundy, C (2012). Can stress reduction interventions improve psoriasis? A review. Psychol Health Med, eScholarID:198860 | PMID:23116223 | DOI:10.1080/13548506.2012.736625
  • Foulkes, A., Griffiths, C., Chinoy, H. & Warren, R (2012). Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis. J Dermatolog Treat, eScholarID:180723 | PMID:22812533 | DOI:10.3109/09546634.2012.713460
  • Foulkes, A., Griffiths, C., Chinoy, H. & Warren, R (2012). Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis. J Dermatolog Treat, eScholarID:198890 | PMID:22812533 | DOI:10.3109/09546634.2012.713460
  • Griffiths, C (2012). Commentary: Biologics for psoriasis: steps to heaven 17. Br J Dermatol, 167(4), 715-6. eScholarID:180704 | PMID:23013314 | DOI:10.1111/bjd.12026
  • Griffiths, C (2012). Commentary: Biologics for psoriasis: steps to heaven 17. Br J Dermatol, 167(4), 715-6. eScholarID:198863 | PMID:23013314 | DOI:10.1111/bjd.12026
  • Griffiths, C. & Girolomoni, G (2012). Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis? J Eur Acad Dermatol Venereol, 26 Suppl 5, 2-8. eScholarID:180730 | PMID:22758911 | DOI:10.1111/j.1468-3083.2012.04604.x
  • Griffiths, C. & Girolomoni, G (2012). Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis? J Eur Acad Dermatol Venereol, 26 Suppl 5, 2-8. eScholarID:198866 | PMID:22758911 | DOI:10.1111/j.1468-3083.2012.04604.x
  • Gunn, D., de Craen, A., Dick, J., Tomlin, C., van Heemst, D., Catt, S., Griffiths, T., Ogden, S., Maier, A., Murray, P., Griffiths, C., Slagboom, P. & Westendorp, R (2012). Facial Appearance Reflects Human Familial Longevity and Cardiovascular Disease Risk in Healthy Individuals. J Gerontol A Biol Sci Med Sci, eScholarID:180726 | PMID:22879455 | DOI:10.1093/gerona/gls154
  • Hébert, H., Ali, F., Bowes, J., Griffiths, C., Barton, A. & Warren, R (2012). Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. Br J Dermatol, 166(3), 474-82. eScholarID:180708 | PMID:22050552 | DOI:10.1111/j.1365-2133.2011.10712.x
  • Hébert, H., Ali, F., Bowes, J., Griffiths, C., Barton, A. & Warren, R (2012). Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. Br J Dermatol, 166(3), 474-82. eScholarID:198873 | PMID:22050552 | DOI:10.1111/j.1365-2133.2011.10712.x
  • Kleyn, C., McKie, S., Ross, A., Elliott, R. & Griffiths, C (2012). A temporal analysis of the central neural processing of itch. Br J Dermatol, 166(5), 994-1001. eScholarID:180697 | PMID:22283926 | DOI:10.1111/j.1365-2133.2012.10849.x
  • Kleyn, C., McKie, S., Ross, A., Elliott, R. & Griffiths, C (2012). A temporal analysis of the central neural processing of itch. Br J Dermatol, 166(5), 994-1001. eScholarID:198819 | PMID:22283926 | DOI:10.1111/j.1365-2133.2012.10849.x
  • Knight, J., Spain, S., Capon, F., Hayday, A., Nestle, F., Clop, A., , , , , , , Barker, J., Weale, M. & Trembath, R (2012). Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis. Hum Mol Genet, 21(23), 5185-92. eScholarID:198926 | PMID:22914738 | DOI:10.1093/hmg/dds344
  • Langan, E., Griffiths, C. & Paus, R (2012). Exploring the role of prolactin in psoriasis. Arch Dermatol Res, 304(2), 115-8. eScholarID:180722 | PMID:22249743 | DOI:10.1007/s00403-012-1208-6
  • Langan, E., Griffiths, C. & Paus, R (2012). Exploring the role of prolactin in psoriasis. Arch Dermatol Res, 304(2), 115-8. eScholarID:198867 | PMID:22249743 | DOI:10.1007/s00403-012-1208-6
  • Langton, A., Griffiths, C., Sherratt, M. & Watson, R (2012). Cross-linking of structural proteins in ageing skin: an in situ assay for the detection of amine oxidase activity. Biogerontology, eScholarID:180706 | PMID:22923173 | DOI:10.1007/s10522-012-9394-3
  • Langton, A., Sherratt, M., Griffiths, C. & Watson, R (2012). Differential expression of elastic fibre components in intrinsically aged skin. Biogerontology, 13(1), 37-48. eScholarID:180709 | PMID:21461665 | DOI:10.1007/s10522-011-9332-9
  • Laws, P., Downs, A., Parslew, R., Dever, B., Smith, C., Barker, J., Moriarty, B., Murphy, R., Kirby, B., Burden, A., McBride, S., Anstey, A., O'Shea, S., Ralph, N., Buckley, C., Griffiths, C. & Warren, R (2012). Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. Br J Dermatol, 166(1), 189-95. eScholarID:180727 | PMID:21929536 | DOI:10.1111/j.1365-2133.2011.10638.x
  • Laws, P., Downs, A., Parslew, R., Dever, B., Smith, C., Barker, J., Moriarty, B., Murphy, R., Kirby, B., Burden, A., McBride, S., Anstey, A., O'Shea, S., Ralph, N., Buckley, C., Griffiths, C. & Warren, R (2012). Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. Br J Dermatol, 166(1), 189-95. eScholarID:198883 | PMID:21929536 | DOI:10.1111/j.1365-2133.2011.10638.x
  • Lebwohl, M., Leonardi, C., Griffiths, C., Prinz, J., Szapary, P., Yeilding, N., Guzzo, C., Li, S., Hsu, M. & Strober, B (2012). Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. J Am Acad Dermatol, 66(5), 731-41. eScholarID:180724 | PMID:21930328 | DOI:10.1016/j.jaad.2011.06.011
  • Lebwohl, M., Leonardi, C., Griffiths, C., Prinz, J., Szapary, P., Yeilding, N., Guzzo, C., Li, S., Hsu, M. & Strober, B (2012). Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. J Am Acad Dermatol, 66(5), 731-41. eScholarID:198881 | PMID:21930328 | DOI:10.1016/j.jaad.2011.06.011
  • Mrowietz, U., Kragballe, K., Reich, K., Griffiths, C., Gu, Y., Wang, Y. & Rozzo, S (2012). An Assessment of Adalimumab Efficacy in Three Phase III Clinical Trials Using the European Consensus Programme Criteria for Psoriasis Treatment Goals. Br J Dermatol, eScholarID:180702 | PMID:22880843 | DOI:10.1111/j.1365-2133.2012.11214.x
  • Murray, A., Moore, T., Manning, J., Griffiths, C. & Herrick, A (2012). Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts? J Rheumatol, 39(8), 1654-8. eScholarID:180734 | PMID:22753661 | DOI:10.3899/jrheum.111359
  • Murray, A., Moore, T., Manning, J., Griffiths, C. & Herrick, A (2012). Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts? J Rheumatol, 39(8), 1654-8. eScholarID:198878 | PMID:22753661 | DOI:10.3899/jrheum.111359
  • Murray, A., Moore, T., Richards, H., Ennis, H., Griffiths, C. & Herrick, A (2012). Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases. Br J Dermatol, 167(3), 563-9. eScholarID:180735 | PMID:22540211 | DOI:10.1111/j.1365-2133.2012.11019.x
  • Murray, A., Moore, T., Richards, H., Ennis, H., Griffiths, C. & Herrick, A (2012). Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases. Br J Dermatol, 167(3), 563-9. eScholarID:198880 | PMID:22540211 | DOI:10.1111/j.1365-2133.2012.11019.x
  • Nelson, P., Chew-Graham, C., Griffiths, C., Cordingley, L. & . (2012). Recognition of need in health care consultations: a qualitative study of people with Psoriasis. Br J Dermatol, eScholarID:180716 | PMID:22880951 | DOI:10.1111/j.1365-2133.2012.11217.x
  • Parisi, R., Symmons, D., Griffiths, C., Ashcroft, D. & . (2012). Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. J Invest Dermatol, eScholarID:180710 | PMID:23014338 | DOI:10.1038/jid.2012.339
  • Reich, K., Papp, K., Griffiths, C., Szapary, P., Yeilding, N., Wasfi, Y., Ott, E., Hsu, M., Lebwohl, M., Gordon, K. & . (2012). An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. J Drugs Dermatol, 11(3), 300-12. eScholarID:180729 | PMID:22395580
  • Reich, K., Papp, K., Griffiths, C., Szapary, P., Yeilding, N., Wasfi, Y., Ott, E., Hsu, M., Lebwohl, M., Gordon, K. & . (2012). An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. J Drugs Dermatol, 11(3), 300-12. eScholarID:198927 | PMID:22395580
  • Shaw, F., Kimber, I., Begum, R., Cumberbatch, M., Dearman, R. & Griffiths, C (2012). No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis. Clin Exp Dermatol, 37(1), 40-7. eScholarID:180732 | PMID:21933242 | DOI:10.1111/j.1365-2230.2011.04172.x
  • Shaw, F., Kimber, I., Begum, R., Cumberbatch, M., Dearman, R. & Griffiths, C (2012). No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis. Clin Exp Dermatol, 37(1), 40-7. eScholarID:198879 | PMID:21933242 | DOI:10.1111/j.1365-2230.2011.04172.x
  • Thorneloe, R., Bundy, C., Griffiths, C., Ashcroft, D. & Cordingley, L (2012). Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol, eScholarID:180699 | PMID:22963128 | DOI:10.1111/bjd.12039
  • Thurstan, S., Gibbs, N., Langton, A., Griffiths, C., Watson, R. & Sherratt, M (2012). Chemical consequences of cutaneous photoageing. Chem Cent J, 6(1), 34. eScholarID:180703 | PMID:22534143 | DOI:10.1186/1752-153X-6-34
  • Thurstan, S., Gibbs, N., Langton, A., Griffiths, C., Watson, R. & Sherratt, M (2012). Chemical consequences of cutaneous photoageing. Chem Cent J, 6(1), 34. eScholarID:198859 | PMID:22534143 | DOI:10.1186/1752-153X-6-34
  • Tsoi, et al (2012). Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet, 44(12), 1341-8. eScholarID:198869 | PMID:23143594 | DOI:10.1038/ng.2467
  • Yesudian, P., Chalmers, R., Warren, R. & Griffiths, C (2012). In search of oral psoriasis. Arch Dermatol Res, 304(1), 1-5. eScholarID:180713 | PMID:21927905 | DOI:10.1007/s00403-011-1175-3
  • Yesudian, P., Chalmers, R., Warren, R. & Griffiths, C (2012). In search of oral psoriasis. Arch Dermatol Res, 304(1), 1-5. eScholarID:198871 | PMID:21927905 | DOI:10.1007/s00403-011-1175-3

2011

  • Bowes, J., Eyre, S., Flynn, E., Ho, P., Salah, S., Warren, R., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A., Kane, D., Korendowych, E., McHugh, N., FitzGerald, O., Packham, J., Morgan, A., Griffiths, C., Bruce, I., Worthington, J. & Barton, A (2011). Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis, 70(6), 1016-9. eScholarID:126649 | PMID:21349879 | DOI:10.1136/ard.2010.143123
  • Bowes, J., Eyre, S., Flynn, E., Ho, P., Salah, S., Warren, R., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A., Kane, D., Korendowych, E., McHugh, N., FitzGerald, O., Packham, J., Morgan, A., Griffiths, C., Bruce, I., Worthington, J. & Barton, A (2011). Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis, 70(6), 1016-9. eScholarID:180717 | PMID:21349879 | DOI:10.1136/ard.2010.143123
  • Chiang, Y., Tan, K., Chiang, Y., Burge, S., Griffiths, C. & Verbov, J (2011). Evaluation of educational methods in dermatology and confidence levels: a national survey of UK medical students. Int J Dermatol, 50(2), 198-202. eScholarID:126651 | PMID:21244386 | DOI:10.1111/j.1365-4632.2010.04664.x
  • Chiang, Y., Tan, K., Chiang, Y., Burge, S., Griffiths, C. & Verbov, J (2011). Evaluation of educational methods in dermatology and confidence levels: a national survey of UK medical students. Int J Dermatol, 50(2), 198-202. eScholarID:180733 | PMID:21244386 | DOI:10.1111/j.1365-4632.2010.04664.x
  • Chiang, Y., Tosti, A., Chaudhry, I., Lyne, L., Farjo, B., Farjo, N., Cadore de Farias, D., Griffiths, C., Paus, R. & Harries, M (2011). Lichen Planopilaris following Hair Transplantation and Face-lift Surgery. Br J Dermatol, eScholarID:136998 | PMID:21985326 | DOI:10.1111/j.1365-2133.2011.10692.x
  • Foulkes, A., Grindlay, D., Griffiths, C. & Warren, R (2011). What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010. Clin Exp Dermatol, eScholarID:126645 | PMID:21718345 | DOI:10.1111/j.1365-2230.2011.04108.x
  • Foulkes, A., Grindlay, D., Griffiths, C. & Warren, R (2011). What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010. Clin Exp Dermatol, 36(6), 585-9; quiz 588-9. eScholarID:180728 | PMID:21718345 | DOI:10.1111/j.1365-2230.2011.04108.x
  • Foulkes, A., Grindlay, D., Griffiths, C. & Warren, R (2011). What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010. Clin Exp Dermatol, 36(6), 585-9; quiz 588-9. eScholarID:198885 | PMID:21718345 | DOI:10.1111/j.1365-2230.2011.04108.x
  • Hébert, H., Ali, F., Bowes, J., Griffiths, C., Barton, A. & Warren, R (2011). Genetic Susceptibility to Psoriasis and Psoriatic Arthritis: Implications for Therapy. Br J Dermatol, eScholarID:136999 | PMID:22050552 | DOI:10.1111/j.1365-2133.2011.10712.x
  • Langan, E., Griffiths, C. & Paus, R (2011). In search of the source of hyperprolactinaemia in systemic lupus erythematosus. Clin Exp Rheumatol, eScholarID:137000 | PMID:22032729
  • Langton, A., Sherratt, M., Griffiths, C. & Watson, R (2011). Differential expression of elastic fibre components in intrinsically aged skin. Biogerontology, eScholarID:126647 | PMID:21461665 | DOI:10.1007/s10522-011-9332-9
  • Laws, P., Downs, A., Parslew, R., Dever, B., Smith, C., Barker, J., Moriarty, B., Murphy, R., Kirby, B., Burden, A., McBride, S., Anstey, A., O'Shea, S., Ralph, N., Buckley, C., Griffiths, C. & Warren, R (2011). Practical experience of Ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. Br J Dermatol, eScholarID:137006 | PMID:21929536 | DOI:10.1111/j.1365-2133.2011.10638.x
  • Lebwohl, M., Leonardi, C., Griffiths, C., Prinz, J., Szapary, P., Yeilding, N., Guzzo, C., Li, S., Hsu, M. & Strober, B (2011). Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. J Am Acad Dermatol, eScholarID:137007 | PMID:21930328 | DOI:10.1016/j.jaad.2011.06.011
  • Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Daudén, E., Gisondi, P., Iversen, L., Kemény, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B. & Yawalkar, N (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res, 303(1), 1-10. eScholarID:126653 | PMID:20857129 | DOI:10.1007/s00403-010-1080-1
  • Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Daudén, E., Gisondi, P., Iversen, L., Kemény, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B. & Yawalkar, N (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res, 303(1), 1-10. eScholarID:180705 | PMID:20857129 | DOI:10.1007/s00403-010-1080-1
  • Newman, W., Payne, K., Tricker, K., Roberts, S., Fargher, E., Pushpakom, S., Alder, J., Sidgwick, G., Payne, D., Elliott, R., Heise, M., Elles, R., Ramsden, S., Andrews, J., Houston, J., Qasim, F., Shaffer, J., Griffiths, C., Ray, D., Bruce, I. & Ollier, W (2011). A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics, 12(6), 815-26. eScholarID:126646 | PMID:21692613 | DOI:10.2217/pgs.11.32
  • Newman, W., Payne, K., Tricker, K., Roberts, S., Fargher, E., Pushpakom, S., Alder, J., Sidgwick, G., Payne, D., Elliott, R., Heise, M., Elles, R., Ramsden, S., Andrews, J., Houston, J., Qasim, F., Shaffer, J., Griffiths, C., Ray, D., Bruce, I., Ollier, W. & . (2011). A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics, 12(6), 815-26. eScholarID:180693 | PMID:21692613 | DOI:10.2217/pgs.11.32
  • Newman, W., Payne, K., Tricker, K., Roberts, S., Fargher, E., Pushpakom, S., Alder, J., Sidgwick, G., Payne, D., Elliott, R., Heise, M., Elles, R., Ramsden, S., Andrews, J., Houston, J., Qasim, F., Shaffer, J., Griffiths, C., Ray, D., Bruce, I., Ollier, W. & . (2011). A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics, 12(6), 815-26. eScholarID:198818 | PMID:21692613 | DOI:10.2217/pgs.11.32
  • Ogden, S., Dearman, R., Kimber, I. & Griffiths, C (2011). The effect of ageing on phenotype and function of monocyte-derived Langerhans cells. Br J Dermatol, 165(1), 184-8. eScholarID:126648 | PMID:21410677 | DOI:10.1111/j.1365-2133.2011.10313.x
  • Ogden, S., Dearman, R., Kimber, I. & Griffiths, C (2011). The effect of ageing on phenotype and function of monocyte-derived Langerhans cells. Br J Dermatol, 165(1), 184-8. eScholarID:180720 | PMID:21410677 | DOI:10.1111/j.1365-2133.2011.10313.x
  • Reich, K., Langley, R., Lebwohl, M., Szapary, P., Guzzo, C., Yeilding, N., Li, S., Hsu, M. & Griffiths, C (2011). Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol, 164(4), 862-72. eScholarID:126652 | PMID:21332467 | DOI:10.1111/j.1365-2133.2011.10257.x
  • Reich, K., Langley, R., Lebwohl, M., Szapary, P., Guzzo, C., Yeilding, N., Li, S., Hsu, M. & Griffiths, C (2011). Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol, 164(4), 862-72. eScholarID:180700 | PMID:21332467 | DOI:10.1111/j.1365-2133.2011.10257.x
  • Shaw, F., Kimber, I., Begum, R., Cumberbatch, M., Dearman, R. & Griffiths, C (2011). No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis. Clin Exp Dermatol, eScholarID:137004 | PMID:21933242 | DOI:10.1111/j.1365-2230.2011.04172.x
  • van de Kerkhof, P., Barker, J., Griffiths, C., Menter, A., Leonardi, C., Young, M., Kemeny, L., Pincelli, C., Bachelez, H., Katsambas, A., Ståhle, M., Horn, E., Sterry, W. & . (2011). Improving clinical trial design in psoriasis: Perspectives from the global dermatology community. J Dermatolog Treat, 22(4), 187-93. eScholarID:180711 | PMID:20887207 | DOI:10.3109/09546634.2010.487888
  • Warren, R., Smith, R., Flynn, E., Bowes, J., , , Eyre, S., Worthington, J., Barton, A. & Griffiths, C (2011). A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2/IL21. Br J Dermatol, 164(3), 660-4. eScholarID:126650 | PMID:21375519 | DOI:10.1111/j.1365-2133.2011.10237.x
  • Warren, R., Smith, R., Flynn, E., Bowes, J., , , Eyre, S., Worthington, J., Barton, A. & Griffiths, C (2011). A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2/IL21. Br J Dermatol, 164(3), 660-4. eScholarID:180696 | PMID:21375519 | DOI:10.1111/j.1365-2133.2011.10237.x
  • Yesudian, P., Chalmers, R., Warren, R. & Griffiths, C (2011). In search of oral psoriasis. Arch Dermatol Res, eScholarID:137005 | PMID:21927905 | DOI:10.1007/s00403-011-1175-3

2010

  • , et al (2010). A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet, 42(11), 985-90. eScholarID:180694 | PMID:20953190 | DOI:10.1038/ng.694
  • , et al (2010). A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet, 42(11), 985-90. eScholarID:96597 | PMID:20953190 | DOI:10.1038/ng.694
  • Christophers, E., Barker, J., Griffiths, C., Daudén, E., Milligan, G., Molta, C., Sato, R. & Boggs, R (2010). The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol, 24(5), 548-54. eScholarID:126643 | PMID:19874432 | DOI:10.1111/j.1468-3083.2009.03463.x
  • Graham, H., Hodson, N., Hoyland, J., Millward-Sadler, S., Garrod, D., Scothern, A., Griffiths, C., Watson, R., Cox, T., Erler, J., Trafford, A. & Sherratt, M (2010). Tissue section AFM: In situ ultrastructural imaging of native biomolecules. Matrix Biol, 29(4), 254-60. eScholarID:126642 | PMID:20144712 | DOI:10.1016/j.matbio.2010.01.008
  • Graham, H., Hodson, N., Hoyland, J., Millward-Sadler, S., Garrod, D., Scothern, A., Griffiths, C., Watson, R., Cox, T., Erler, J., Trafford, A. & Sherratt, M (2010). Tissue section AFM: In situ ultrastructural imaging of native biomolecules. Matrix Biol, 29(4), 254-60. eScholarID:81255 | PMID:20144712 | DOI:10.1016/j.matbio.2010.01.008
  • Griffiths, C (2010). Comparing biological therapies in psoriasis: implications for clinical practice. J Eur Acad Dermatol Venereol, 24 Suppl 6, 10-4. eScholarID:126630 | PMID:20831704 | DOI:10.1111/j.1468-3083.2010.03831.x
  • Griffiths, C (2010). Comparing biological therapies in psoriasis: implications for clinical practice. J Eur Acad Dermatol Venereol, 24 Suppl 6, 10-4. eScholarID:180707 | PMID:20831704 | DOI:10.1111/j.1468-3083.2010.03831.x
  • Griffiths, C (2010). Comparing biological therapies in psoriasis: implications for clinical practice. J Eur Acad Dermatol Venereol, 24 Suppl 6, 10-4. eScholarID:96599 | PMID:20831704 | DOI:10.1111/j.1468-3083.2010.03831.x
  • Griffiths, C (2010). Management of psoriasis in pregnancy: time to deliver? Br J Dermatol, 163(2), 235. eScholarID:126632 | PMID:20666767 | DOI:10.1111/j.1365-2133.2010.09925.x
  • Griffiths, C (2010). Management of psoriasis in pregnancy: time to deliver? Br J Dermatol, 163(2), 235. eScholarID:180725 | PMID:20666767 | DOI:10.1111/j.1365-2133.2010.09925.x
  • Griffiths, C., Strober, B., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., Dooley, L., Goldstein, N., Menter, A. & . (2010). Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med, 362(2), 118-28. eScholarID:81257 | PMID:20071701 | DOI:10.1056/NEJMoa0810652
  • Griffiths, C., Strober, B., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., Dooley, L., Goldstein, N., Menter, A. & . (2010). Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis. The New England journal of medicine, 362(2), 118. eScholarID:126641 | PMID:20071701 | DOI:10.1056/NEJMoa0810652
  • Harries, M., Meyer, K., Chaudhry, I., Griffiths, C. & Paus, R (2010). Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? Clin Exp Dermatol, 35(6), 637-44. eScholarID:126644 | PMID:19886964 | DOI:10.1111/j.1365-2230.2009.03692.x
  • Langan, E., Ramot, Y., Hanning, A., Poeggeler, B., Bíró, T., Gaspar, E., Funk, W., Griffiths, C. & Paus, R (2010). Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol, 162(5), 1127-31. eScholarID:126639 | PMID:20302576 | DOI:10.1111/j.1365-2133.2010.09676.x
  • Langan, E., Ramot, Y., Hanning, A., Poeggeler, B., Bíró, T., Gaspar, E., Funk, W., Griffiths, C. & Paus, R (2010). Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol, 162(5), 1127-31. eScholarID:81252 | PMID:20302576 | DOI:10.1111/j.1365-2133.2010.09676.x
  • Langton, A., Sherratt, M., Griffiths, C. & Watson, R (2010). A new wrinkle on old skin: the role of elastic fibres in skin ageing. Int J Cosmet Sci, eScholarID:126635 | PMID:20572890 | DOI:10.1111/j.1468-2494.2010.00574.x
  • Langton, A., Sherratt, M., Griffiths, C. & Watson, R (2010). A new wrinkle on old skin: the role of elastic fibres in skin ageing. Int J Cosmet Sci, eScholarID:180695 | PMID:20572890 | DOI:10.1111/j.1468-2494.2010.00574.x
  • Langton, A., Sherratt, M., Griffiths, C. & Watson, R (2010). A new wrinkle on old skin: the role of elastic fibres in skin ageing. Int J Cosmet Sci, eScholarID:96596 | PMID:20572890 | DOI:10.1111/j.1468-2494.2010.00574.x
  • Menter, A., Griffiths, C., Tebbey, P., Horn, E., Sterry, W. & . (2010). Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol, eScholarID:81267 | PMID:20384692 | DOI:10.1111/j.1468-3083.2010.03656.x
  • Menter, A., Griffiths, C., Tebbey, P., Horn, E., Sterry, W. & . (2010). Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol, 24(12), 1371-7. eScholarID:126640 | PMID:20384692 | DOI:10.1111/j.1468-3083.2010.03656.x
  • Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Daudén, E., Gisondi, P., Iversen, L., Kemény, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B. & Yawalkar, N (2010). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res, eScholarID:96600 | PMID:20857129 | DOI:10.1007/s00403-010-1080-1
  • Munz, O., Sela, S., Baker, B., Griffiths, C., Powles, A. & Fry, L (2010). Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res, 302(7), 495-8. eScholarID:126633 | PMID:20607546 | DOI:10.1007/s00403-010-1065-0
  • Munz, O., Sela, S., Baker, B., Griffiths, C., Powles, A. & Fry, L (2010). Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res, 302(7), 495-8. eScholarID:180731 | PMID:20607546 | DOI:10.1007/s00403-010-1065-0
  • Munz, O., Sela, S., Baker, B., Griffiths, C., Powles, A. & Fry, L (2010). Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res, 302(7), 495-8. eScholarID:96601 | PMID:20607546 | DOI:10.1007/s00403-010-1065-0
  • Reich, K., Ortonne, J., Kerkmann, U., Wang, Y., Saurat, J., Papp, K., Langley, R. & Griffiths, C (2010). Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial. Dermatology, 221(2), 172-8. eScholarID:126634 | PMID:20628238 | DOI:10.1159/000317775
  • Reich, K., Ortonne, J., Kerkmann, U., Wang, Y., Saurat, J., Papp, K., Langley, R. & Griffiths, C (2010). Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial. Dermatology, 221(2), 172-8. eScholarID:180721 | PMID:20628238 | DOI:10.1159/000317775
  • Shaw, F., Cumberbatch, M., Kleyn, C., Begum, R., Dearman, R., Kimber, I. & Griffiths, C (2010). Langerhans Cell Mobilization Distinguishes between Early-Onset and Late-Onset Psoriasis. J Invest Dermatol, eScholarID:81254 | PMID:20237494 | DOI:10.1038/jid.2010.57
  • Sherratt, M., Bayley, C., Reilly, S., Gibbs, N., Griffiths, C. & Watson, R (2010). Low-dose ultraviolet radiation selectively degrades chromophore-rich extracellular matrix components. J Pathol, 222(1), 32-40. eScholarID:126636 | PMID:20552716 | DOI:10.1002/path.2730
  • Sherratt, M., Bayley, C., Reilly, S., Gibbs, N., Griffiths, C. & Watson, R (2010). Low-dose ultraviolet radiation selectively degrades chromophore-rich extracellular matrix components. J Pathol, 222(1), 32-40. eScholarID:180715 | PMID:20552716 | DOI:10.1002/path.2730
  • Sherratt, M., Bayley, C., Reilly, S., Gibbs, N., Griffiths, C. & Watson, R (2010). Low-dose ultraviolet radiation selectively degrades chromophore-rich extracellular matrix components. J Pathol, 222(1), 32-40. eScholarID:96603 | PMID:20552716 | DOI:10.1002/path.2730
  • Strange, et al (2010). A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature Genetics, 42(11), 985. eScholarID:126628 | PMID:20953190 | DOI:10.1038/ng.694
  • van de Kerkhof, P., Barker, J., Griffiths, C., Menter, A., Leonardi, C., Young, M., Kemeny, L., Pincelli, C., Bachelez, H., Katsambas, A., St X00e5 Hle, M., Horn, E. & Sterry, W (2010). Improving clinical trial design in psoriasis: Perspectives from the global dermatology community. J Dermatolog Treat, eScholarID:126629 | PMID:20887207 | DOI:10.3109/09546634.2010.487888
  • van de Kerkhof, P., Barker, J., Griffiths, C., Menter, A., Leonardi, C., Young, M., Kemeny, L., Pincelli, C., Bachelez, H., Katsambas, A., St X00e5 Hle, M., Horn, E. & Sterry, W (2010). Improving clinical trial design in psoriasis: Perspectives from the global dermatology community. J Dermatolog Treat, eScholarID:96602 | PMID:20887207 | DOI:10.3109/09546634.2010.487888
  • Warren, R. & Griffiths, C (2010). The future of biological therapies. Semin Cutan Med Surg, 29(1), 63-6. eScholarID:126637 | PMID:20430310 | DOI:10.1016/j.sder.2010.02.004
  • Warren, R. & Griffiths, C (2010). The future of biological therapies. Semin Cutan Med Surg, 29(1), 63-6. eScholarID:81251 | PMID:20430310 | DOI:10.1016/j.sder.2010.02.004
  • Warren, R., Brown, B., Grindlay, D. & Griffiths, C (2010). What's new in psoriasis? Analysis of the clinical significance of new guidelines and systematic reviews on psoriasis published in 2008 and 2009. Clin Exp Dermatol, 35(7), 688-91; quiz 692. eScholarID:126638 | PMID:20545953 | DOI:10.1111/j.1365-2230.2010.03880.x
  • Warren, R., Brown, B., Lavery, D. & Griffiths, C (2010). Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol, eScholarID:96598 | PMID:20716225 | DOI:10.1111/j.1365-2133.2010.09986.x
  • Warren, R., Brown, B., Lavery, D. & Griffiths, C (2010). Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol, 163(4), 859-62. eScholarID:126631 | PMID:20716225 | DOI:10.1111/j.1365-2133.2010.09986.x
  • Warren, R., Brown, B., Lavery, D. & Griffiths, C (2010). Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol, 163(4), 859-62. eScholarID:180698 | PMID:20716225 | DOI:10.1111/j.1365-2133.2010.09986.x

2009

  • Brown BC, Warren RB, Grindlay DJ, Griffiths CEM. (2009). What's new in psoriasis? Analysis of the clinical significance of systematic reviews on psoriasis published in 2007 and 2008. Clin Exp Dermatol, eScholarID:1d20234 | DOI:10.1111/j.1365-2230.2009.03414.x
  • Christophers, E., Barker, J., Griffiths, C., Daudén, E., Milligan, G., Molta, C., Sato, R. & Boggs, R (2009). The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol, eScholarID:81268 | PMID:19874432 | DOI:10.1111/j.1468-3083.2009.03463.x
  • Daudén E, Griffiths CEM, Ortonne JP, Kragballe K, Molta C, Robertson D, Pedersen R, Estojak J, Boggs R. (2009). Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study. J Eur Acad Dermatol Venereol, eScholarID:1d20249 | DOI:10.1111/j.1468-3083.2009.03321.x
  • Daudén, E., Griffiths, C., Ortonne, J., Kragballe, K., Molta, C., Robertson, D., Pedersen, R., Estojak, J. & Boggs, R (2009). Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study. J Eur Acad Dermatol Venereol, 23(12), 1374-82. eScholarID:126619 | PMID:19563497 | DOI:10.1111/j.1468-3083.2009.03321.x
  • Dubertret, L., Chimenti, S., Christophers, E., Daudén, E., de Rie, M., Griffiths, C., Kragballe, K., Ståhle, M. & Stingl, G (2009). Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts. Br J Dermatol, 161 Suppl 2, 1-30. eScholarID:126617 | PMID:19594542 | DOI:10.1111/j.1365-2133.2009.09173.x
  • Dubertret, L., Chimenti, S., Christophers, E., Daudén, E., de Rie, M., Griffiths, C., Kragballe, K., Ståhle, M. & Stingl, G (2009). Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts. Br J Dermatol, 161 Suppl 2, 1-30. eScholarID:81266 | PMID:19594542 | DOI:10.1111/j.1365-2133.2009.09173.x
  • Eedy, D., Griffiths, C., Chalmers, R., Ormerod, A., Smith, C., Barker, J., Potter, J., Ingham, J., Lowe, D. & Burge, S (2009). Care of patients with psoriasis: an audit of U.K. services in secondary care. Br J Dermatol, 160(3), 557-64. eScholarID:126627 | PMID:19120330 | DOI:10.1111/j.1365-2133.2008.08987.x
  • Ford, C., Sherratt, M., Griffiths, C. & Watson, R (2009). Liver X receptor beta: maintenance of epidermal expression in intrinsic and extrinsic skin aging. Age (Dordr), eScholarID:81262 | PMID:19697157 | DOI:10.1007/s11357-009-9111-6
  • Ford, C., Sherratt, M., Griffiths, C. & Watson, R (2009). Liver X receptor β: maintenance of epidermal expression in intrinsic and extrinsic skin aging. Age (Dordr), 31(4), 365-72. eScholarID:126614 | PMID:19697157 | DOI:10.1007/s11357-009-9111-6
  • Gunn, D., Rexbye, H., Griffiths, C., Murray, P., Fereday, A., Catt, S., Tomlin, C., Strongitharm, B., Perrett, D., Catt, M., Mayes, A., Messenger, A., Green, M., van der Ouderaa, F., Vaupel, J. & Christensen, K (2009). Why some women look young for their age. PLoS One, 4(12), e8021. eScholarID:126610 | PMID:19956599 | DOI:10.1371/journal.pone.0008021
  • Gunn, D., Rexbye, H., Griffiths, C., Murray, P., Fereday, A., Catt, S., Tomlin, C., Strongitharm, B., Perrett, D., Catt, M., Mayes, A., Messenger, A., Green, M., van der Ouderaa, F., Vaupel, J. & Christensen, K (2009). Why some women look young for their age. PLoS One, 4(12), e8021. eScholarID:81258 | PMID:19956599 | DOI:10.1371/journal.pone.0008021
  • Harries MJ, Trueb RM, Tosti A, Messenger AG, Chaudhry I, Whiting DA, Sinclair R, Griffiths CEM, Paus RR. (2009). How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol, eScholarID:1d18484 | DOI:10.1111/j.1365-2133.2008.09008.x
  • Harries, M., Meyer, K., Chaudhry, I., Griffiths, C. & Paus, R (2009). Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? Clin Exp Dermatol, eScholarID:81259 | PMID:19886964 | DOI:10.1111/j.1365-2230.2009.03692.x
  • Harries, M., Trueb, R., Tosti, A., Messenger, A., Chaudhry, I., Whiting, D., Sinclair, R., Griffiths, C. & Paus, R (2009). How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol, 160(3), 482-501. eScholarID:126625 | PMID:19183169 | DOI:10.1111/j.1365-2133.2008.09008.x
  • Kaczvinsky, J., Griffiths, C., Schnicker, M. & Li, J (2009). Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. J Cosmet Dermatol, 8(3), 228-33. eScholarID:126612 | PMID:19735523 | DOI:10.1111/j.1473-2165.2009.00444.x
  • Kaczvinsky, J., Griffiths, C., Schnicker, M. & Li, J (2009). Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. J Cosmet Dermatol, 8(3), 228-33. eScholarID:81261 | PMID:19735523 | DOI:10.1111/j.1473-2165.2009.00444.x
  • Kleyn, C., McKie, S., Ross, A., Montaldi, D., Gregory, L., Elliott, R., Isaacs, C., Anderson, I., Richards, H., Deakin, J., Fortune, D. & Griffiths, C (2009). Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. J Invest Dermatol, 129(11), 2613-9. eScholarID:126613 | PMID:19710691 | DOI:10.1038/jid.2009.152
  • Kleyn, CE, McKie, S, Ross, A, Montaldi, D, Gregory, LJ, Elliott, R, Isaacs, C, Anderson, I, Richards, HL, Deakin, JFW, Fortune, D, Griffiths, CEM. (2009). Diminished Neural and Cognitive Responses to Facial Expressions of Disgust in Patients with Psoriasis: A Functional Magnetic Resonance Imaging Study. Journal of Investigative Dermatology, 129(11), 2613-2619. eScholarID:1d21110 | DOI:10.1038/jid.2009.152
  • Madan V, Chinoy H, Griffiths CEM, Cooper R. (2009). Defining cancer risk in dermatomyositis. Part I. Clin Exp Dermatol, 34( 4), 451-5. eScholarID:1d19579 | DOI:10.1111/j.1365-2230.2009.03216.x
  • Madan V, Chinoy H, Griffiths CEM, Cooper R. (2009). Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology. Clin Exp Dermatol, 34( 5), 561-5. eScholarID:1d19580 | DOI:10.1111/j.1365-2230.2009.03227.x
  • Madan, V., Chinoy, H., Griffiths, C. & Cooper, R (2009). Defining cancer risk in dermatomyositis. Part I. Clin Exp Dermatol, 34(4), 451-5. eScholarID:126622 | PMID:19522981 | DOI:10.1111/j.1365-2230.2009.03216.x
  • Madan, V., Chinoy, H., Griffiths, C. & Cooper, R (2009). Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology. Clin Exp Dermatol, 34(5), 561-5. eScholarID:126623 | PMID:19508476 | DOI:10.1111/j.1365-2230.2009.03227.x
  • Murray AK, Moore TL, Griffiths CEM, Herrick AL. (2009). An investigation into the blood-flow characteristics of telangiectatic skin lesions in systemic sclerosis using dual-wavelength laser Doppler imaging. Clin Exp Dermatol, 34(5), 618-620. eScholarID:1d19239 | DOI:10.1111/j.1365-2230.2008.03170.x
  • Murray, A., Moore, T., Griffiths, C. & Herrick, A (2009). An investigation into the blood-flow characteristics of telangiectatic skin lesions in systemic sclerosis using dual-wavelength laser Doppler imaging. Clin Exp Dermatol, 34(5), 618-20. eScholarID:126624 | PMID:19438531 | DOI:10.1111/j.1365-2230.2008.03170.x
  • Murray, A., Moore, T., Manning, J., Taylor, C., Griffiths, C. & Herrick, A (2009). Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum, 61(8), 1103-11. eScholarID:126616 | PMID:19644893 | DOI:10.1002/art.24645
  • Murray, A., Moore, T., Manning, J., Taylor, C., Griffiths, C. & Herrick, A (2009). Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum, 61(8), 1103-11. eScholarID:81263 | PMID:19644893 | DOI:10.1002/art.24645
  • Quaranta M, Burden AD, Griffiths CEM, Worthington J, Barker JN, Trembath RC, Capon F. (2009). Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun, 10(7), 654-658. eScholarID:1d20233 | DOI:10.1038/gene.2009.51
  • Quaranta, M., Burden, A., Griffiths, C., Worthington, J., Barker, J., Trembath, R. & Capon, F (2009). Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun, 10(7), 654-8. eScholarID:126620 | PMID:19587699 | DOI:10.1038/gene.2009.51
  • Robinson, M., Binder, R. & Griffiths, C (2009). Genomic-driven insights into changes in aging skin. J Drugs Dermatol, 8(7 Suppl), s8-11. eScholarID:126618 | PMID:19623778
  • Robinson, M., Binder, R. & Griffiths, C (2009). Genomic-driven insights into changes in aging skin. J Drugs Dermatol, 8(7 Suppl), s8-11. eScholarID:81264 | PMID:19623778
  • Rutter K, Watson REB, Cotterell LF, Brenn TT, Griffiths CEM, Rhodes LE. (2009). Severely Photosensitive Psoriasis - A Phenotypically Defined Patient Subset. Journal Of Investigative Dermatology, eScholarID:1d28361
  • Rutter, K., Watson, R., Cotterell, L., Brenn, T., Griffiths, C. & Rhodes, L (2009). Severely photosensitive psoriasis: a phenotypically defined patient subset. J Invest Dermatol, 129(12), 2861-7. eScholarID:126621 | PMID:19536141 | DOI:10.1038/jid.2009.156
  • Smith, C., Anstey, A., Barker, J., Burden, A., Chalmers, R., Chandler, D., Finlay, A., Griffiths, C., Jackson, K., McHugh, N., McKenna, K., Reynolds, N., Ormerod, A. & . (2009). British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol, 161(5), 987-1019. eScholarID:126611 | PMID:19857207 | DOI:10.1111/j.1365-2133.2009.09505.x
  • Smith, C., Anstey, A., Barker, J., Burden, A., Chalmers, R., Chandler, D., Finlay, A., Griffiths, C., Jackson, K., McHugh, N., McKenna, K., Reynolds, N., Ormerod, A. & . (2009). British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol, 161(5), 987-1019. eScholarID:81260 | PMID:19857207 | DOI:10.1111/j.1365-2133.2009.09505.x
  • Smith, R., Warren, R., Griffiths, C. & Worthington, J (2009). Genetic susceptibility to psoriasis: an emerging picture. Genome Med, 1(7), 72. eScholarID:126615 | PMID:19638187 | DOI:10.1186/gm72
  • Smith, R., Warren, R., Griffiths, C. & Worthington, J (2009). Genetic susceptibility to psoriasis: an emerging picture. Genome Med, 1(7), 72. eScholarID:81265 | PMID:19638187 | DOI:10.1186/gm72
  • Warren RB, Brown BC, Lavery D, Ashcroft DM, Griffiths CEM. (2009). Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol, 160, 162-169. eScholarID:1d18114 | DOI:10.1111/j.1365-2133.2008.08865.x
  • Warren RB, Smith R, Campalani E, Eyre SS, Smith CH, Barker JN, Worthington J, Griffiths CEM. (2009). Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. Br J Dermatol, 160 (2), 438-441. eScholarID:1d18204 | DOI:10.1111/j.1365-2133.2008.08898.x
  • Warren, R. & Griffiths, C (2009). Future therapeutic directions for the treatment of psoriasis. Actas Dermosifiliogr, 100 Suppl 2, 28-31. eScholarID:126609 | PMID:20096159 | DOI:10.1016/S0001-7310(09)73375-7
  • Warren, R. & Griffiths, C (2009). Future therapeutic directions for the treatment of psoriasis. Actas Dermosifiliogr, 100 Suppl 2, 28-31. eScholarID:81256 | PMID:20096159 | DOI:10.1016/S0001-7310(09)73375-7
  • Watson REB, Ogden S, Cotterell LF, Bowden JJ, Bastrilles JY, Long SP, Griffiths CEM. (2009). A cosmetic ‘anti-ageing’ product improves photoaged skin: a double-blind, randomized controlled trial. British Journal of Dermatology, 161(2), 419. eScholarID:1d32489 | DOI:10.1111/j.1365-2133.2009.09216.x
  • Watson, R., Ogden, S., Cotterell, L., Bowden, J., Bastrilles, J., Long, S. & Griffiths, C (2009). Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. Br J Dermatol, 161(2), 419-26. eScholarID:126626 | PMID:19438432 | DOI:10.1111/j.1365-2133.2009.09216.x

2008

  • Eedy, D, Griffiths, CEM, Chalmers, R, Ormerod, A, Smith, C, Barker, J, Potter, J, Ingham, J, Lowe, D, Burge, S. (2008). Care of patients with psoriasis: an audit of U.K. services in secondary care. Br J Dermatol, eScholarID:1d18485 | DOI:10.1111/j.1365-2133.2008.08987.x
  • Filer C, Ho PY, Smith R, Griffiths CEM, Young H, Worthington J, Bruce IN, Barton A. (2008). Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis & Rheumatism, 58(12), 3705. eScholarID:1d18217 | DOI:10.1002/art.24128
  • Harries M, Sinclair R, Macdonald-Hull S, Whiting D, Griffiths CEM, Paus RR. (2008). Management of primary cicatricial alopecias: options for treatment. Br J Dermatol, 159( 1), 1-22. eScholarID:1d18207 | DOI:10.1111/j.1365-2133.2008.08591.x
  • Hussain W, Ogden S, Lavery D, Griffiths CEM. (2008). Making a 'point' about the safe disposal of sharps in patients on biological therapies. Br J Dermatol, 159( 2), 491-2. eScholarID:1d18205 | DOI:10.1111/j.1365-2133.2008.08639.x
  • Kirby B, Richards H, Mason D, Fortune D, Main C, Griffiths CEM. (2008). Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol, 158( 1), 138-40. eScholarID:1d18195 | DOI:10.1111/j.1365-2133.2007.08299.x
  • Kleyn, C., Schneider, L., Saraceno, R., Mantovani, C., Richards, H., Fortune, D., Cumberbatch, M., Dearman, R., Terenghi, G., Kimber, I. & Griffiths, C (2008). The Effects of Acute Social Stress on Epidermal Langerhans' Cell Frequency and Expression of Cutaneous Neuropeptides. J Invest Dermatol, 128(5), 1273-1279. eScholarID:126792 | PMID:17989731 | DOI:10.1038/sj.jid.5701144
  • Lübeck, R, Berneburg, M, Trelles, M, Friguet, B, Ogden, S, Esrefoglu, M, Kaya, G, Goldberg, D, Mordon, S, Calderhead, R, Griffiths, CEM, Saurat, J, Thappa, D. (2008). How best to halt and/or revert UV-induced skin ageing: strategies, facts and fiction. Exp Dermatol, 17( 3), 228-40. eScholarID:1d18210 | DOI:10.1111/j.1600-0625.2007.00665_1.x
  • Ogden S, Griffiths CEM. (2008). Viewpoint 2. Exp Dermatol, 17( 3), 230-231. eScholarID:1d18202 | DOI:10.1111/j.1600-0625.2007.00665_2.x
  • Ogden S, Samuel M, Griffiths CEM. (2008). A review of tazarotene in the treatment of photodamaged skin. Clin Interv Aging, 3( 1), 71-6. eScholarID:1d18208
  • Reich K, Griffiths CEM. (2008). The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab. Arch Dermatol Res, 300( 10), 537-44. eScholarID:1d18116 | DOI:10.1007/s00403-008-0885-7
  • Reich K, Sinclair R, Roberts G, Griffiths CEM, Tabberer M, Barker J. (2008). Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. Curr Med Res Opin, 24( 5), 1237-54. eScholarID:1d18209 | DOI:10.1185/030079908X291985
  • Rich P, Griffiths CEM, Reich K, Nestle F, Scher R, Li S, Xu S, Hsu M, Guzzo C. (2008). Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol, 58( 2), 224-31. eScholarID:1d18191 | DOI:10.1016/j.jaad.2007.07.042
  • Richards H, Fortune D, Griffiths CEM. (2008). The Greater Patient concept. Br J Dermatol, 158( 1), 176-8. eScholarID:1d18198 | DOI:10.1111/j.1365-2133.2007.08247.x
  • Skvara, H, Dawid, M, Kleyn, E, Wolff, B, Meingassner, J, Knight, H, Dumortier, T, Kopp, T, Fallahi, N, Stary, G, Burkhart, C, Grenet, O, Wagner, J, Hijazi, Y, Morris, R, McGeown, C, Rordorf, C, Griffiths, CEM, Stingl, G, Jung, T. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. Journal of Clinical Investigation, 118(9), 3151-9. eScholarID:1d18118 | DOI:10.1172/JCI35636
  • van de Kerkhof P, Barker J, Griffiths CEM, Kragballe K, Mason J, Menter A, Papp K. (2008). Psoriasis: consensus on topical therapies. J Eur Acad Dermatol Venereol, 22( 7), 859-70. eScholarID:1d18192 | DOI:10.1111/j.1468-3083.2007.02534.x
  • Warren RB, Brown B, Griffiths CEM. (2008). Topical treatments for scalp psoriasis. Drugs, 68( 16), 2293-302. eScholarID:1d18113
  • Warren RB, Chalmers R, Griffiths CEM, Menter A. (2008). Methotrexate for psoriasis in the era of biological therapy. Clin Exp Dermatol, 33( 5), 551-4. eScholarID:1d18115 | DOI:10.1111/j.1365-2230.2008.02976.x
  • Warren RB, Griffiths CEM. (2008). Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol, 26( 5), 438-47. eScholarID:1d18117 | DOI:10.1016/j.clindermatol.2007.11.006
  • Warren RB, Smith R, Campalani E, Eyre SS, Smith CH, Barker JN, Worthington J, Griffiths CEM. (2008). Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J Invest Dermatol, 128 (8), 1925-1929. eScholarID:1d17073
  • Wolf, N, Quaranta, M, Prescott, N, Allen, M, Smith, R, Burden, A, Worthington, J, Griffiths, CEM, Mathew, C, Barker, J, Capon, F, Trembath, R. (2008). Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet, 45 (2), 114-6. eScholarID:1d18197 | DOI:10.1136/jmg.2007.053595
  • Woods, A, Rutter, K, Gardner, L, Lewis, V, Saxena, S, George, S, Chalmers, R, Griffiths, CEM, Speight, E, Anstey, A, Ronda, L, McGibbon, D, Barker, J, Smith, C. (2008). Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol, 158( 2), 266-72. eScholarID:1d18193 | DOI:10.1111/j.1365-2133.2007.08338.x
  • Smith R, Warren RB, Eyre SS, Ho PY, Ke X, Young H, Griffiths CEM, Worthington J. (2008). Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol, 128( 5), eScholarID:17d699
  • Ho, P, Barton, A, Worthington, J, Plant, D, Griffiths, CEM, Young, H, Bradburn, P, Thomson, W, Silman, A, Bruce, I. (2008). Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. ( 67( 5), ). England: Academic Press. eScholarID:5d78 | DOI:10.1136/ard.2007.071399
  • Warren RB, Brown BC, Carmichael AJ, Griffiths CEM. (2008). Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate. Wiley. eScholarID:5d229 | DOI:10.1111/j.1365-2230.2008.02946.x

2007

  • Farwick M, Watson REB, Rawlings A, Wollenweber U, Lersch P, Bowden JJ, Bastrilles J, Griffiths CEM. (2007). Salicyloyl-phytosphingosine: a novel agent for the repair of photoaged skin. Int J Cosmet Sci, 29( 4), 319-29. eScholarID:1d18119 | DOI:10.1111/j.1467-2494.2007.00394.x
  • Griffiths CEM, Barker J. (2007). Pathogenesis and clinical features of psoriasis. Lancet, 370( 9583), 263-71. eScholarID:1d18201 | DOI:10.1016/S0140-6736(07)61128-3
  • Griffiths CEM, JNWN Barker. (2007). Psoriasis: background and clinical features. The Lancet, eScholarID:1d15819
  • Griffiths, CEM, E Christophers, JNWN Barker, Chalmers, RJG, S Chimenti, GG Krueger, C Leonardi, A Menter, J-P Ortonne, L Fry. (2007). A classification of psoriasis vulgaris according to phenotype. British Journal of Dermatology, 156, 258-262. eScholarID:1d15049 | DOI:10.1111/j.1365-2133.2006.07675.x
  • M Schmuth, Watson REB, D Deplewski, S Dubrac, SS Zouboulis, Griffiths CEM. (2007). Nuclear hormone receptors in human skin. Hormone and Metabolic Research, 39, 96-105. eScholarID:1d15818 | DOI:10.1055/s-2007-961808
  • Madan V, Griffiths CEM. (2007). Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther, 20( 4), 239-50. eScholarID:1d31931 | DOI:10.1111/j.1529-8019.2007.00137.x
  • Menter A, Griffiths CEM. (2007). Current and future management of psoriasis. Lancet, 370( 9583), 272-84. eScholarID:1d18200 | DOI:10.1016/S0140-6736(07)61129-5
  • Reich K, Nestle F, Wu Y, Bala M, Eisenberg D, Guzzo C, Li S, Dooley L, Griffiths CEM. (2007). Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. Eur J Dermatol, 17( 5), 381-6. eScholarID:1d32129 | DOI:10.1684/ejd.2007.0234
  • Seston E, Ashcroft D, Griffiths CEM. (2007). Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis. Arch Dermatol, 143( 9), 1175-9. eScholarID:1d18199 | DOI:10.1001/archderm.143.9.1175
  • Watson REB, R Poddar, JM Walker, I McGuill, LM Hoare, Griffiths CEM, O'Neill CA. (2007). Altered claudin expression is a feature of chronic plaque psoriasis. Journal of Pathology, 212, 450-8. eScholarID:1d15823 | DOI:10.1002/path.2200
  • Watson REB, S P Long, Bowden JJ, Bastrilles J, S P Barton, Griffiths CEM. (2007). Repair of photoaged dermal matrix by topical application of cosmetic anti-ageing products. British Journal Of Dermatology, eScholarID:1d27407
  • Y Zhao, A Terron-Kwiatkowski, H Liau, SP Lee, MH Allen, PR Hull, LM Campbell, RC Trembath, F Capon, Griffiths, CEM, D Burden, R McManus, R Hughes, B Kirby, O Fitzgerald, D Kane, JNWN Barker, CAN Palmer, AD Irvine, WHI McLean. (2007). Filaggrin null alleles are not associated with psoriasis patients. Journal of Investigative Dermatology, eScholarID:1d15821 | DOI:10.1038/sj.jid.5700817

2006

  • Cotterell LF, Rutter K, Brenn T, Chalmers RJG, Griffiths CEM, Watson REB, Rhodes LE. (2006). Low dose UVB challenge causes early histological abnormalities in uninvolved skin of patients with photosensitive psoriasis. Academic Press. eScholarID:2d2042
  • Cotterell LF, Rutter K, Brenn T, Chalmers RJG, Griffiths CEM, Watson REB, Rhodes LE. (2006). Role of memory effector T lymphocytes in the early phase of photosensitive psoriasis. Academic Press. eScholarID:2d2530
  • Rutter K, Cotterell LF, Brownrigg M, Watson REB, Chalmers RJG, Griffiths CEM, Rhodes LE. (2006). Clinical and photobiological characteristics of patients with photosensitive psoriasis. Academic Press. eScholarID:2d2064
  • Ashcroft DM, Seston EM, Griffiths CEM. (2006). Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. British Journal Of Dermatology, 155, 1236-1241. eScholarID:1d27328 | DOI:10.1111/j.1365-2133.2006.07535.x
  • CO Mendonca, Griffiths CEM. (2006). Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. British Journal of Dermatology, 154, 977-978. eScholarID:1d12976 | DOI:10.1111/j.1365-2133.2006.07155.x
  • E Campalani, MH Allen, D Fairhurst, Young, H, CO Mendonca, AD Buren, Griffiths, CEM, MA Crook, JN Barker, CH Smith. (2006). Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. British Journal of Dermatology, 154, 345-352. eScholarID:1d12875 | DOI:10.1111/j.1365-2133.2005.06950.x
  • E Christophers, Griffiths CEM, G Gaitanis, P van de Kerkhof. (2006). The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review. Journal of European Academy of Venereology, 20, 921-925. eScholarID:1d13848 | DOI:10.1111/j.1468-3083.2006.01667.x
  • Griffiths CEM, A Katsambas, BAC Dijkmans, AY Finlay, VC Ho, A Johnston, T Luger, U Mrowietz, K Thestrup-Pederson. (2006). Update on the use of ciclosporin in immune-mediated dermatoses. British Journal of Dermatology, 155, 1-16. eScholarID:1d12908 | DOI:10.1111/j.1365-2133.2006.07343.x
  • Griffiths CEM, Andrew Finlay, Colin Fleming, Jonathan Barker, Fabienne Mizzi, Stephanie Arsonnaud. (2006). A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. Journal of Dermatological Treatment, 17, 90-95. eScholarID:1d13335 | DOI:10.1080/09546630500515701
  • Griffiths CEM, H Taylor, S I Collins, Hobson J, P A Collier, Chalmers RJG, Stewart EJC, P Dey. (2006). The impact of psoriasis guidelines on the appropriateness of referral from primary to secondary care: a randomised controlled trial. British Journal of Dermatology, 155, 393-400. eScholarID:1d13478 | DOI:10.1111/j.1365-2133.2006.07354.x
  • Griffiths CEM, L Iaccarino, L Naldi, N Pipitone, C Salvarani, A Doria. (2006). Psoriasis and psoriatic arthritis: Immunological aspects and therapeutic guidelines. Clinical and Experimental Rheumatology, 24, S72-S78. eScholarID:1d12878
  • GSS Atwal, LK Manku, Griffiths CEM, Polson DW. (2006). Striae gravidarum in primiparae. British Journal of Dermatology, 155, 965-9. eScholarID:1d13482 | DOI:10.1111/j.1365-2133.2006.07427.x
  • K Reich, FO Nestle, K Papp, JP Ortonne, Y Wu, M Bala, R Evans, C Guzzo, S Li, LT Dooley, Griffiths, CEM. (2006). Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. British Journal of Dermatology, 154, 1161-1168. eScholarID:1d12905 | DOI:10.1111/j.1365-2133.2006.07237.x
  • Kleyn CE, Griffiths CEM. (2006). Infliximab for the treatment of psoriasis. Expert Opinion on Biological Therapy, 6, 797-805. eScholarID:1d13492 | DOI:10.1517/14712598.6.8.797
  • L Stewart, A Roberts, Warren RB, Griffiths CEM. (2006). Using biological therapies for psoriasis and other inflammatory dermatoses. Dermatology in Practice, 14, 18-21. eScholarID:1d13847
  • Marie Cumberbatch, M Singh, Rebecca Dearman, Young H, I Kimber, Griffiths CEM. (2006). Impaired Langerhans' cell migration in psoriasis. The Journal of Experimental Medicine, 203, 953-960. eScholarID:1d12906 | DOI:10.1084/jem.20052367
  • Minal Singh, Griffiths CEM. (2006). The use of retinoids in the treatment of photoaging. Dermatologic Therapy, 19, 297-305. eScholarID:1d13849 | DOI:10.1111/j.1529-8019.2006.00087.x
  • MJ Harries, E McMullen, Griffiths CEM. (2006). Pyoderma gangrenosum masquerading as dermatitis artefacta. Archives of Dermatology, 142, 1509-10. eScholarID:1d12910
  • N MacDonald, Marie Cumberbatch, M Singh, JG Moggs, G Orphanides, Rebecca Dearman, Griffiths CEM. (2006). Proteomic analysis of suction blister fluid isolated from human skin. Clin Exp Derm, 31, 445-448. eScholarID:1d12907 | DOI:10.1111/j.1365-2230.2006.02078.x
  • Plant D, Watson REB, Young H, Worthington J, Griffiths CEM. (2006). The CX3CL1-CX3CR1 system and psoriasis. Experimental Dermatology, 15 (11), 900-903. eScholarID:1d13538
  • R Saraceno, Griffiths CEM. (2006). A European perspective on the challenges of managing psoriasis. Journal of the American Academy of Dermatology, 54, S81-S84. eScholarID:1d12879 | DOI:10.1016/j.jaad.2005.10.051
  • R Saraceno, Kleyn CE, Terenghi G, Griffiths CEM. (2006). The role of neuropeptides in psoriasis. British Journal of Dermatology, 154, 876-882. eScholarID:1d13480 | DOI:10.1111/j.1365-2133.2006.07518.x
  • Richards HE, Fortune DG, Griffiths CEM. (2006). Adherence to treatment in patients with psoriasis. Journal of European Acadamy of Dermatology and Venerology, 20, 370-379. eScholarID:1d11187 | DOI:10.1111/j.1468-3083.2006.01565.x
  • Richards HL, Donal G Fortune, Griffiths CEM. (2006). Adherence to treatment in patients with psoriasis. Journal of the European Academy of Dermatology and Venerology, 20, 370-379. eScholarID:1d7890 | DOI:10.1111/j.1468-3083.2006.01565.x
  • SE Clements, S Abdul-Ghaffer, Griffiths CEM. (2006). Biological therapy for psoriasis. Br J of Hospital Medicine, 67, 184-187. eScholarID:1d12904
  • Tsoureli-Nikita E, Watson REB, Griffiths CEM. (2006). Photoageing: The darker side of the sun. Photochemical and Photobiological Sciences, 5, eScholarID:1d11086
  • Warren RB, Griffiths CEM. (2006). Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going? Future Prescriber Article, 7, 1-7. eScholarID:1d12880
  • Young, H, Angela M Summers, Ian Read, David A Fairhurst, Plant, D, Emanuela Campalani, Catherine H Smith, Jonathan NWN Barker, Michael J Detmar, Brenchley, PEC, Griffiths, CEM. (2006). Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. Journal of investigative dermatology, 126, 453-459. eScholarID:1d26801 | DOI:10.1038/sj.jid.5700096

2005

  • C Mendonca, Griffiths CEM. (2005). Psoriasis: future drugs. Medicine. ( 33:1, pp. 56-57). Academic Press. eScholarID:3d388
  • Winhoven SM, Blackburn A, Griffiths CEM, Gibbs NK. (2005). Paul Langerhans: the man and 'his' cell. Academic Press. eScholarID:2d1745
  • AB Gottlieb, Griffiths, CEM, VC HO, M Lahfa, U Mrowietz, DF Murrell, JP Ortonne, G Todd, R Cherill, I Marks, S Emady-Azar, CF Paul. (2005). Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. British Journal of Dermatology, 152, 1219-27. eScholarID:1d10932 | DOI:10.1111/j.1365-2133.2005.06661.x
  • DA Fairhurst, Ashcroft DM, Griffiths CEM. (2005). Optimal Management of Severe Plaque Form of Psoriasis. American Journal of Clinical Dermatology, 6, 283-94. eScholarID:1d25906 | DOI:10.2165/00128071-200506050-00002
  • DG Fortune, Richards HL, Griffiths CEM, Main CJ. (2005). Worry and pathological worry in patients with psoriasis: cross sectional and longitudinal analysis of the Penn State Worry Questionnaire in four samples of patients. Journal of Clinical Psychology in Medical Settings, 12, 143-152. eScholarID:1d10839 | DOI:10.1007/s10880-005-3274-9
  • DG Fortune, Richards HL, Griffiths CEM. (2005). Psychological factors in psoriasis: consequences, mechanisms and interventions. Dermatology Clinics, 23, 681-694. eScholarID:1d10842 | DOI:10.1016/j.det.2005.05.022
  • Fortune D, Richards HL, Griffiths CEM, Main CJ. (2005). Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events. Psychology, Health and Medicine, 10, 44-56. eScholarID:1d9246 | DOI:10.1080/13548500512331315352
  • GG Krueger, RG Langley, AY Finlay, Griffiths CEM, JM Woolley, D Lalla, A Jahreis. (2005). Interaction between Genetic Control of Vascular Endothelial Growth Factor Production and Retinoid Responsiveness in Psoriasis. Journal of Investigative Dermatology, 153, 1192-1199. eScholarID:1d12877
  • Griffiths CEM, Dearman RJ, Cumberbatch M, Kimber I. (2005). Cytokines and langerhans cell mobilisation in mouse and man. Cytokine, 32(2), 67-70. eScholarID:1d11189
  • Griffiths CEM, S Maddin, O Wiedow, R Marks, AE Donald. (2005). Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens. Journal Dermatoligical Treatment, 16, 79-86. eScholarID:1d10943 | DOI:10.1080/09546630510027732
  • Griffiths CEM. (2005). Ciclosporin in psoriasis consensus statement: reply from authors. British Journal of Dermatology, 152, eScholarID:1d10935
  • Griffiths CEM. (2005). Controversies in experimental dermatology. Experimental Dermatology, 14, 398-9. eScholarID:1d10936 | DOI:10.1111/j.0906-6705.2005.0323b.x
  • Grueger GG, Langley RG, Finlay AY, Griffiths CEM, Woolley JM, Lalla D, Jahreis A. (2005). Patient-Reported outcomes of psoriasis improvement with Etanercept therapy: Results of a randomized phase 3 trial. British Journal of Dermatology, eScholarID:1d11188
  • Harries M, Chalmers RJG, Griffiths CEM. (2005). Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol, 153( 3), 549-51. eScholarID:1d11977
  • Hinks, AM, Barton, A, John, S, Bruce, IN, Hawkins, C, Griffiths, CEM, Donn, RP, Thomson, W, Silman, AJ, Worthington, J. (2005). Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum, 52( 6), 1694-9. eScholarID:1d11755 | DOI:10.1002/art.21049
  • Ho, PY, Bruce, IN, Silman, AJ, Symmons, D, Newman, WG, Young, H, Griffiths, CEM, John, S, Worthington, J, Barton, A. (2005). Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum, 52( 11), 3596-3602. eScholarID:1d11751 | DOI:10.1002/art.21393
  • K Papp, S Tyring, M Lahfa, J Prinz, Griffiths CEM, AM Nakanishi, R Zitnik, P van de Kerkhof. (2005). A Global Phase 3 study of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. British Journal of Dermatology, 152, 1304-12. eScholarID:1d10933 | DOI:10.1111/j.1365-2133.2005.06688.x
  • Kristian Reich, Frank O Nestle, Kim Papp, Jean-Paul Ortonne, Robert Evans, Cynthia Guzzo, Shu Li, Lisa T Dooley, Griffiths CEM. (2005). Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet, 366, 1367-1374. eScholarID:1d11574 | DOI:10.1016/S0140-6736(05)66916-4
  • L Naldi, Griffiths CEM. (2005). Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. British Journal of Dermatology, 152, 597-615. eScholarID:1d10937 | DOI:10.1111/j.1365-2133.2005.06563.x
  • Lovatt, T, Lear, JT, Bastrilles, J, Wong, C, Griffiths, CEM, Samarasinghe, V, Roebuck, J, Ramachandran, S, Smith, A, Jones, P, Fryer, A, Strange, R. (2005). Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol, 52( 3 Pt 1), 468-73. eScholarID:1d11945 | DOI:10.1016/j.jaad.2004.08.060
  • M Allen, M Ameen, J Evans, C Veal, J Leman, AM Marsland, D Burden, Griffiths, CEM, RC Trembath, JNWN Barker. (2005). The major psoriasis susceptibility locus PSORS1, is not a risk factor for late onset psoriasis. Journal of Investigative Dermatology, 124, 103-6. eScholarID:1d9452 | DOI:10.1111/j.0022-202X.2004.23511.x
  • Murray AK, Herrick AL, Moore TL, King TA, Griffiths CEM. (2005). Dual wavelength (532 and 633nm) laser Doppler imaging of plaque psoriasis. British Journal of Dermatology, 152, 1182-1186. eScholarID:1d12853 | DOI:10.1111/j.1365-2133.2005.06479.x
  • P van de Kerkhof, Griffiths CEM, E Christophers, M Lebwohl, GG Krueger. (2005). Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate. Dermatology, 211, 256-263. eScholarID:1d12977 | DOI:10.1159/000087020
  • RG Langley, GG Krueger, Griffiths CEM. (2005). Psoriasis: epidemiology, clinical features, and quality of life. Annals of Rheumatic Diseases, 64, 18-23. eScholarID:1d10942 | DOI:10.1136/ard.2004.033217
  • Richards HL, Fortune D, Griffiths CEM, Chris J Main. (2005). Alexithymia patients with psoriasis; clinical correlates and psychometric properties of the TAS-20. Journal of Psychosomatic Research, 58, 89-96. eScholarID:1d7820
  • Richards HL, Ray DW, B Kirby, D Mason, Plant D, CJ Main, DG Fortune, Griffiths CEM. (2005). Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. British Journal of Dermatology, 153, 1114-1120. eScholarID:1d10837 | DOI:10.1111/j.1365-2133.2005.06817.x
  • S Kyle, D Chandler, Griffiths CEM, P Helliwell, J Lewis, I McInnes, S Oliver, Symmons D, N McHugh. (2005). BSR Guideline for Anti-TNF(alpha) Therapy in psoriatic arthritis. Rheumatology, 44, 390-7. eScholarID:1d10940 | DOI:10.1093/rheumatology/keh514
  • SA Ghaffar, SE Clements, Griffiths CEM. (2005). Modern management of psoriasis. 5, 564-568. eScholarID:1d12876
  • Smith, C, Anstey, A, Barker, J, Burden, A, Chalmers, RJG, Chandler, D, Finlay, A, Griffiths, CEM, Jackson, K, McHugh, N, McKenna, K, Reynolds, N, Ormerod, A, NULL. (2005). British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol, 153( 3), 486-97. eScholarID:1d11979 | DOI:10.1111/j.1365-2133.2005.06893.x
  • Trevor N Brooklyn, Giles Dunnill, Ajeya Shetty, Bowden JJ, Jason Williams, Griffiths CEM, Alastair Forbes, Rosemary Greenwood, Chris Probert. (2005). Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial. Gut, 55, 505-509. eScholarID:1d12978 | DOI:10.1136/gut.2005.074815
  • V Quekenborn-Trinquet, P Fogel, O Aldana-Jammayrac, P Ancian, M Demarchez, Richards, HL, B Kirby, C Nguyen, JJ Voegel, Griffiths, CEM. (2005). Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. British Journal of Dermatology, 152, 482-504. eScholarID:1d10939 | DOI:10.1111/j.1365-2133.2005.06384.x
  • Watson REB, Griffiths CEM. (2005). Pathogenic aspects of cutaneous photoageing. Journal of Cosmetic Dermatology, 4, eScholarID:1d11085
  • Winhoven S, Griffiths CEM. (2005). What GPs need to know about TNF-alpha inhibitors. Dermatology in Practice, 13, 22-24. eScholarID:1d11185
  • Young H, Griffiths CEM. (2005). Efalizumab: a viewpoint. Americal Journal of Clinical Dermatology, 6, 119-20. eScholarID:1d10938
  • Payne, K, Fargher, EA, Tricker, K, Newman, WG, Qasim, FF, Poulton, K, Andrews, J, Houston, JB, Elliott, RA, Elles, R, Ray, DW, Shaffer, JL, Griffiths, CEM, Bruce, IN, Roberts, S A, Olier, WER. (2005). Research Governance: What is reasonable protection? BMJ Rapid Response, eScholarID:17d508
  • Seston EM, Ashcroft DM, Griffiths CEM. (2005). Examining patients' preferences for the treatment of psoriasis. eScholarID:5d93

2004

  • AM Marsland, Griffiths CEM. (2004). Therapeutic potential of macrolide immunosuppressants in dermatology. Expert Opin Investig Drugs, 13, 125-37. eScholarID:1d7783 | DOI:10.1517/13543784.13.2.125
  • CO Mendonca, Griffiths CEM. (2004). Side effects of systemic treatment for psoriasis. Retinoids, 20, 72-75. eScholarID:1d10941
  • Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CEM. (2004). Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. Journal of Investigative Dermatology, 123, 484-487. eScholarID:1d7891 | DOI:10.1111/j.0022-202X.2004.23314.x
  • EC Benton, Griffiths CEM. (2004). Biologic therapy for psoriasis. Sri Lanka Journal of Dermatology, 8, 1-7. eScholarID:1d10934
  • Fortune D, Richards HL, Griffiths CEM, Main C. (2004). Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol, 43( Pt 1), 65-82. eScholarID:1d9232
  • Fortune D, Richards HL, Kirby B, McElhone K, Main C, Griffiths CEM. (2004). Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol, 151( 6), 1219-26. eScholarID:1d9228
  • Griffiths CEM. (2004). Competency assessment of dermatology trainees in the United Kingdom. Clinical and Experimental Dermatology, 29, 571-575. eScholarID:1d7818 | DOI:10.1111/j.1365-2230.2004.01569.x
  • Griffiths CEM. (2004). New therapies for psoriasis. British Journal of Dermatology Nursing, 8, 10-12. eScholarID:1d7817 | DOI:10.1111/j.1346-8138.2010.00789.x
  • Griffiths CEM. (2004). Psoriasis: future research needs and goals for the twenty-first century. Dermatology Clinics, 22, 493-499. eScholarID:1d9450 | DOI:10.1016/j.det.2003.12.001
  • Griffiths CEM. (2004). T cell targeted biologicals for psoriasis. Inflammation and Allergy, eScholarID:1d7735
  • Griffiths, CEM, L Dubertret, CN Ellis, AY Finlay, AF Finzi, VC Ho, A Johnston, A Katsambas, A-E Lison, JM Naeyaert, H Nakagawa, C Paul, F Vanaclocha. (2004). Ciclosporin in psoriasis clinical practice: an international consensus statement. British Journal of Dermatology, 150, 11-23. eScholarID:1d7893 | DOI:10.1111/j.0366-077X.2004.05949.x
  • Plant D, Lear JT, A Marsland, Worthington J, Griffiths CEM. (2004). CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type 1 psoriasis. British Journal of Dermatology, 151, 3, 675-8. eScholarID:1d7734
  • R J Dearman, Bhushan M, M Cumberbatch, I Kimber, Griffiths CEM. (2004). Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation. Experimental Dermatology, 13, 452-60. eScholarID:1d7732 | DOI:10.1111/j.0906-6705.2004.00199.x
  • Richards HL, Fortune D, Chong S, Mason DL, Sweeney S, Main CJ, Griffiths CEM. (2004). Divergent beliefs about psoriasis are associated with increased psychological distress. J Invest Dermatol, 123( 1), 49-56. eScholarID:1d9231
  • Richards HL, Fortune D, Weidmann A, Sweeney S, Griffiths CEM. (2004). Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol, 151( 6), 1227-33. eScholarID:1d9227
  • Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CEM, Donn RP. (2004). Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab, 89( 2), 892-7. eScholarID:1d8136
  • TJ Lovatt, Lear, JT, Bastrilles, J, C Wong, Griffiths, CEM, S Ramachandran, AG Smith, A Salim, AA Fryer, PW Jones, RC Strange. (2004). Association between UVR exposure and basal cell carcinoma site and histology. Cancer Letters, 216, 191-7. eScholarID:1d9498 | DOI:10.1016/j.canlet.2004.08.008
  • W Sterry, Griffiths CEM. (2004). Biological therapies in the management of psoriasis: International Consensus Conference. British Journal of Dermatology, 151, 3-17. eScholarID:1d8470 | DOI:10.1111/j.1365-2133.2004.06070.x
  • Watson REB, JA Ratnayaka, RCC Brooke, S Yee-Sit-Ye, P Ancian, Griffiths CEM. (2004). Retinoic acid receptor alpha expression and cutaneous ageing. Mechanism of Ageing and Development, 125, 465-473. eScholarID:1d7821 | DOI:10.1016/j.mad.2004.03.008
  • Wittkowski A, Richards HL, Griffiths CEM, Main C. (2004). The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res, 57( 2), 195-200. eScholarID:1d9229
  • Young H, Summers AM, Bhushan M, Brenchley PEC, Griffiths CEM. (2004). Single-Nucleotide Polymorphisms of Vascular Endothelial Growth Factor (VEGF) in Psoriasis of Early Onset. Journal of Investigative Dermatology, 122, 209-215. eScholarID:1d7611 | DOI:10.1046/j.0022-202X.2003.22107.x

2003

  • J M Walker, L M Hoare, Griffiths CEM, O'Neill CA, Watson REB. (2003). Claudin expression in healthy skin and chronic plaque psoriasis. eScholarID:2d1533
  • C Young, MH Allen, A Cuthbert, M Ameen, C Veal, J Leman, AD Burden, B Kirby, Griffiths, CEM, RC Trembath, CG Mathew, JNWN Barker. (2003). A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis. Experimental Dermatology, 12, 506-9. eScholarID:1d5330 | DOI:10.1034/j.1600-0625.2002.120420.x
  • Cameron A, Kirby B, Griffiths CEM. (2003). Circulating Natural Killer Cells in Psoriasis. British Journal of Dermatology, 149, 160-164. eScholarID:1d5327 | DOI:10.1046/j.1365-2133.2003.05319.x
  • Chalmers RJG, Griffiths CEM. (2003). Resetting the research agenda for psoriasis. J Invest Dermatol, 120( 5), ix-x. eScholarID:1d11985
  • CL Wong, JB Houghton, S Andrew, Griffiths CEM. (2003). Papuloerythroderma of Ofuji associated with acute myeloid leukaemia. Clinical & Experimental Dermatology, 28, 277-79. eScholarID:1d5329 | DOI:10.1046/j.1365-2230.2003.01260.x
  • Donal G Fortune, Helen L Richards-, A Corrin, RJ Taylor, Griffiths CEM, Christopher J Main. (2003). Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis. Journal of Behavioural Medicine, 26, 211-4. eScholarID:1d5335 | DOI:10.1023/A:1023408503807
  • Donal G Fortune, Helen L Richards, Brian Kirby, K McElhone, T Markham, S Rogers, Christopher J Main, Griffiths CEM. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy (PUVA). Archives of Dermatology, 139, 752-6. eScholarID:1d5331 | DOI:10.1001/archderm.139.6.752
  • Donal G Fortune, Richards HL, AR Corrin, RJ Taylor, Chris J Main, Griffiths CEM. (2003). Automatic vigilance for psoriasis-specific and psychosocial threat in patients with psoriasis. Journal of Behavioural Medicine, 26, 211-224. eScholarID:1d7210 | DOI:10.1023/A:1023408503807
  • Fortune D, Richards HL, Corrin A, Taylor R, Griffiths CEM, Main C. (2003). Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis. J Behav Med, 26( 3), 211-24. eScholarID:1d9235
  • Fortune D, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main C, Griffiths CEM. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol, 139( 6), 752-6. eScholarID:1d9236
  • Griffiths CEM. (2003). The immunological basis of psoriasis. Journal of the European Academy of Dermatology and Venereology, 17, 1-5. eScholarID:1d5333 | DOI:10.1046/j.1468-3083.17.s2.1.x
  • JNWN Barker, J Berth-Jones, R Groves, AD Omerod, E Rizova, Griffiths CEM. (2003). Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3ug/g ointment: no correlation with extent of psoriasis. Journal of Dermatological Treatment, 14, 14-21. eScholarID:1d5337 | DOI:10.1080/09546630305543
  • JP Ortonne, M Lebwohl, Griffiths CEM. (2003). Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. European Journal of Dermatology, 13, 117-23. eScholarID:1d5334
  • K Asumalahti, M Ameen, S Suomela, E Hagforsen, G Michaelsson, J Evans, C Veal, M Allen, J Leman, D Burden, B Kirby, M Connelly, Griffiths, CEM, R Trembath, J Kere, U Saarialho-Kere, JNWN Barker. (2003). Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. Journal of Investigative Dermatology, 120, 627-632. eScholarID:1d5338 | DOI:10.1046/j.1523-1747.2003.12094.x
  • LingT.C, Herrick AL, AndrewS.M, BrammahT, Griffiths CEM. (2003). Keloidal scleroderma. Clinical and Experimental Dermatology, 28, 2, 171-173. eScholarID:1d25082 | DOI:10.1046/j.1365-2230.2003.01220.x
  • Little M, Griffiths CEM, Watson REB, Pemberton MB, Thornhill M. (2003). Oral mucosal keratinocytes express RANTES and ICAM-I but not interleukin-8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings. Clinical & Experimental Dermatology, 28, 64-69. eScholarID:1d24268 | DOI:10.1046/j.1365-2230.2003.01158.x
  • M Cumberbatch-, M Bhushan, RJ Dearman, I Kimber, Griffiths CEM. (2003). IL-1B-induced Langerhans cell migration and TNF-alpha production in human skin: Regulation by Lactoferrin. Clinical & Experimental Immunology, 132, 352-59. eScholarID:1d5336 | DOI:10.1046/j.1365-2249.2003.02146.x
  • M Cumberbatch, RJ Dearman, Griffiths CEM, I Kimber. (2003). Epidermal Langerhans cell migration and sensitization to chemical allergans. APMIS, 111, 797-804. eScholarID:1d6940 | DOI:10.1034/j.1600-0463.2003.11107811.x
  • M Lebwohl, E Christophers, R Langley, JP Ortonne, J Roberts, Griffiths CEM. (2003). An international, randomized, double-blind, placebo-controlled Phase 3 trial of intramuscular Alefacept in patients with chronic plaque psoriasis. Archives of Dermatology, 139, 719-27. eScholarID:1d5332 | DOI:10.1001/archderm.139.6.719
  • Sewon Kang, Michael Goldfarb, Jonathan Weiss, Russell Metz, Ted A Hamilton, John J Voorhees, Griffiths CEM. (2003). Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomised trial. Journal of the American Academy of Dermatology, 49, 83-90. eScholarID:1d5328 | DOI:10.1067/mjd.2003.451
  • SP McKenna, SA Cook, Whalley D, LC Doward, HL Richards, Griffiths CEM, D Van Assche. (2003). Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. British Journal of Dermatology, 149, 323-331. eScholarID:1d6462 | DOI:10.1046/j.1365-2133.2003.05492.x
  • Young H, Griffiths CEM. (2003). Immunotherapy in Psoriasis. Giornale Italiano di Dermatologia e Venereologia, 138, 349-354. eScholarID:1d7609
  • Young H, Griffiths CEM. (2003). New biological response modifiers for inflammatory skin disease. Postgraduate Doctor Caribbean, 19, 82-87. eScholarID:17d895
  • Young H, Griffiths CEM. (2003). Treatment resistance in psoriasis. Doctor, 40-2. eScholarID:17d740

2002

  • Walker S, Rhodes LE, Chatelus Y, Griffiths CEM, Watson REB. (2002). Fibrillin-rich microfibrils are reduced following acute UVB irradiation. eScholarID:2d1204
  • AM Marsland, Griffiths CEM. (2002). The macrolide immunosuppressants in dermatology: mechanisms of action. European Journal of Dermatology, 12, 618-22. eScholarID:1d6874
  • B Kirby, Griffiths CEM. (2002). Novel immune-based therapies for psoriasis. British Journal of Dermatology, 146, 546-551. eScholarID:1d6895 | DOI:10.1046/j.1365-2133.2002.04760.x
  • Bhushan M, Cumberbatch M, Dearman RJ, Andrew S, Kimber I, Griffiths CEM. (2002). Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol, 146, 32-40. eScholarID:1d2503 | DOI:10.1046/j.1365-2133.2002.04549.x
  • Bhushan M, Young H, Brenchley PEC, Griffiths CEM. (2002). Recent advances in cutaneous angiogenesis. Br J Dermatol, 147, 418-25. eScholarID:1d3764 | DOI:10.1046/j.1365-2133.2002.05003.x
  • Bhushan, M, Bleiker, TO, Ballsdon, AE, Allen, MH, Sopwith, M, Robinson, MK, Clarke, C, Weller, RPJB, Graham-Browne, RAC, Keefe, M, Barker, JNWN, Griffiths, CEM. (2002). Anti-E-Selectin in the treatment of psoriasis: a ramdomized trial. British Journal Of Dermatology, 146, 824-831. eScholarID:1d23594 | DOI:10.1046/j.1365-2133.2002.04743.x
  • Cameron A, B Kirby, W Fei, Griffiths CEM. (2002). Natural killer and natural killer-T cells in psoriasis. Archives Dermatological Research, 294, 363-369. eScholarID:1d6887
  • Campbell L, Ladler P, Watson REB, B Kirby, Griffiths CEM, M Gumbleton. (2002). Down-regulation and altered spatial pattern of Caveolin-1 in chronic plaque-type psoriasis. British Journal of Dermatology, 147, 701-709. eScholarID:1d6681 | DOI:10.1046/j.1365-2133.2002.05009.x
  • DK Boyle, A Forsyth, J Bagg, K Stroubou, Griffiths CEM, FJT Burke. (2002). An investigation of the effect of prolonged glove wearing on the skin condition of dental healthcare workers. Journal of Dentistry, 30, 233-41. eScholarID:1d6876 | DOI:10.1016/S0300-5712(02)00014-3
  • Donal G Fortune, Helen L Richards, B Kirby, S Bowcock, Chris J Main, Griffiths CEM. (2002). A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. British Journal of Dermatology, 146, 458-465. eScholarID:1d6899 | DOI:10.1046/j.1365-2133.2002.04622.x
  • Donal G Fortune, Helen L Richards, Griffiths CEM, Chris J Main. (2002). Psychological stress, distress and disability in patients with psoriasis: Consensus and variation in the contribution of illness perceptions, coping and alexithymia. British Journal of Clinical Psychology, 41, 157-174. eScholarID:1d6894 | DOI:10.1348/014466502163949
  • Donal G Fortune, HL Richards, Christopher J Main, Griffiths CEM. (2002). Patients' strategies for coping with psoriasis. Clinical & Experimental Dermatology, 127, 177-185. eScholarID:1d6892 | DOI:10.1046/j.1365-2230.2002.01055.x
  • Fortune D, Richards HL, Griffiths CEM, Main C. (2002). Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol, 41( Pt 2), 157-74. eScholarID:1d9238
  • Griffiths CEM, EJM van Leent, M Gilbert, J Traulsen. (2002). Randomised comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis. British Journal of Dermatology, 147, 299-307. eScholarID:1d6891 | DOI:10.1046/j.1365-2133.2002.04894.x
  • Griffiths CEM. (2002). Epidermal and dermal abnormalities. European Journal of Dermatology, 12, eScholarID:1d6868
  • Griffiths CEM. (2002). Immunotherapy for psoriasis: from serendipity ot selectivity. The Lancet, 359, 279-280. eScholarID:1d7040 | DOI:10.1016/S0140-6736(02)07536-0
  • I Kimber, M Cumberbatch, RJ Dearman, DR Headon, M Bhushan, Griffiths CEM. (2002). Lactoferrin; influences on Langerhans cells, epidermal cytokines and cutaneous inflammation. Biochemistry and Cell Biology, 80, 103-107. eScholarID:1d6896 | DOI:10.1139/o01-227
  • I Kimber, M Cumberbatch, RJ Dearman, Griffiths CEM. (2002). Danger signals and skin sensitization. British Journal of Dermatology, 147, eScholarID:1d6890 | DOI:10.1046/j.1365-2133.2002.48776.x
  • JDL Williams, Griffiths CEM. (2002). Cytokine blocking agents in dermatology. Clinical & Experimental Dermatology, 57, 585-590. eScholarID:1d6869 | DOI:10.1046/j.1365-2230.2002.01149.x
  • M Samuel, Griffiths CEM. (2002). Wrinkles. Clinical Evidence, 7, 1555-65. eScholarID:1d6893
  • PCM Van de Kerkhof, J Berth-Jones, Griffiths CEM, PV Harrison, H Hongismann, R Marks, R Roelandts, E Schopf, C Trompke. (2002). Long-term efficacy and safety of Tacalcitol ointment in patients with chronic plaque psoriasis. British Journal of Dermatology, 146, 414-422. eScholarID:1d6902 | DOI:10.1046/j.1365-2133.2002.04567.x
  • Young H, Chalmers RJG, Griffiths CEM, August P. (2002). CO2 laser vaporization for disfiguring lupus pernio. J Cosmet Laser Ther, 4( 3-4), 87-90. eScholarID:1d11986

2001

  • AM Marsland, Chalmers RJG, Griffiths CEM. (2001). Treatments for chronic palmoplantar pustular psoriasis. Skin Therapy Letter, 12, 3-5. eScholarID:1d6942
  • B Kirby, AS Marsland, AJ Carmichael, Griffiths CEM. (2001). Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate. Clinical & Experimental Dermatology, 26, 27-29. eScholarID:1d6973 | DOI:10.1046/j.1365-2230.2001.00753.x
  • B Kirby, Griffiths CEM. (2001). Psoriasis: the future. British Journal of Dermatology, 37-43, eScholarID:1d6967
  • B Kirby, HL Richards, P Woo, E Hindle, Chris J Main, Griffiths CEM. (2001). Comparison of the Salford Psoriasis Index and other measures of psoriasis severity. Journal of the American Academy of Dermatology, 45, 72-76. eScholarID:1d6962 | DOI:10.1067/mjd.2001.114592
  • CC Lyon, M Stapleton, AJ Smith, S Mendelsohn, MH Beck, Griffiths CEM. (2001). Topical tacrolimus in the management of peristomal pyoderma gangrenosum. Journal of Investigative Dermatology, 116, 13-17. eScholarID:1d6964 | DOI:10.1080/095466301750163518
  • Chalmers RJG, T O'Sullivan, CM Owen, Griffiths CEM. (2001). A systematic review of interventions for guttate psoriasis. British Journal of Dermatology, 145, 891-894. eScholarID:1d6956 | DOI:10.1046/j.1365-2133.2001.04505.x
  • CW Farrar, AS Jack, CC Lyon, RA Cowan, Griffiths CEM, J Ashworth. (2001). A 62-year-old man presenting with widespread nodulo-ulcerative cutaneous lesions. Clinical & Experimental Dermatology, 26, 115-119. eScholarID:1d6972 | DOI:10.1046/j.1365-2230.2001.00745.x
  • Denning DW, Griffiths CEM. (2001). Muco-cutaneous retinoid-effects and photosensitivity related to the novel triazole antifungal agent voriconazole. Clinical & Experimental Dermatology, 145, 648-653. eScholarID:1d6957
  • Griffiths CEM, Cumberbatch M, Tucker SC, Dearman RJ, Andrew S, Headon DR, Kimber I. (2001). Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br J Dermatol, 144, 715-725. eScholarID:1d2498 | DOI:10.1046/j.1365-2133.2001.04125.x
  • Griffiths CEM, HL Richards. (2001). Psychological influences in psoriasis. Clinical & Experimental Dermatology, 26, 338-342. eScholarID:1d6963 | DOI:10.1046/j.1365-2230.2001.00834.x
  • Griffiths CEM, Richards HL. (2001). Psychological influences in psoriasis. Clinical and Experiment Dermatology, 26, 338-342. eScholarID:1d7265 | DOI:10.1046/j.1365-2230.2001.00834.x
  • Griffiths CEM. (2001). Ascomycin: an advance in the management of atopic dermatitis. British Journal of Dermatology, 144, 679-681. eScholarID:1d7038 | DOI:10.1046/j.1365-2133.2001.144004679.x
  • Griffiths CEM. (2001). Keeping psoriasis under wraps. Journal of Dermatological Treatment, 12, eScholarID:1d7039
  • Griffiths CEM. (2001). Psoriasis 2000; the state-of-the-art today ... and tomorrow. British Journal of Dermatology, 144, eScholarID:1d7036
  • Griffiths CEM. (2001). The Role of Retinoids in the Prevention and Repair of Aged and Photoaged Skin. Clinical & Experimental Dermatology, 26, 613-618. eScholarID:1d6958 | DOI:10.1046/j.1365-2230.2001.00892.x
  • HL Richards, DG Fortune, Griffiths CEM, Chris J Main. (2001). The contribution of perceptions of stigmatisation to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11-15. eScholarID:1d6969 | DOI:10.1016/S0022-3999(00)00210-5
  • Little M, Watson REB, Pemberton MB, Griffiths CEM, Thornhill MH. (2001). Activation of oral keratinocytes by mercuric chloride: relevance to dental amalgam-induced oral lichenoid reactions. British Journal of Dermatology, 144, 1024-32. eScholarID:1d3067 | DOI:10.1046/j.1365-2133.2001.04193.x
  • M Bhushan, AD Burden, K McElhone, R James, FP Vanhoutte, Griffiths CEM. (2001). Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomised, double-blind, placebo-controlled study. British Journal of Dermatology, 145, 546-553. eScholarID:1d6959 | DOI:10.1046/j.1365-2133.2001.04411.x
  • NM Craven, CW Jackson, B Kirby, C Perrery, V Pravica, IV Hutchinson, Griffiths CEM. (2001). Cytokine gene polymorphisms in psoriasis. British Journal of Dermatology, 144, 849-853. eScholarID:1d6965 | DOI:10.1046/j.1365-2133.2001.04143.x
  • RCC Brooke, Griffiths CEM. (2001). Folliculitis decalvans. Clinical & Experimental Dermatology, 26, 120-122. eScholarID:1d6970 | DOI:10.1046/j.1365-2230.2001.00746.x
  • RCC Brooke, SA Newbold, NR Telfer, Griffiths CEM. (2001). Discordance between facial wrinkling and basal cell carcinoma. Archives of Dermatology, 137, 751-4. eScholarID:1d6961
  • Reitamo S, P Spuls, B Sassolas, M Lahfa, A Claudy, Griffiths CEM. (2001). Efficacy of sirolimus (Rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasi - a randomised controlled trial. British Journal of Dermatology, 145, 438-445. eScholarID:1d6960 | DOI:10.1046/j.1365-2133.2001.04376.x
  • VCY Ho, Griffiths CEM, J Berth-Jones, KA Papp, F Vanaclocha, E Dauden, A Beard, C Paul, L Puvanarajan. (2001). Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a two-year cohort study. Journal of the American Academy of Dermatology, 44, 643-651. eScholarID:1d6966 | DOI:10.1067/mjd.2001.112400
  • Watson REB, Ball SG, Craven N, Boorsma J, East CL, Shuttleworth CC.A, Kielty CM, Griffiths CEM. (2001). Type VI collagen: Distribution and expression in photoaged skin. British Journal Of Dermatology, 144, eScholarID:1d23899
  • Watson REB, Craven N, Kang S, Jones CJP, Kielty CM, Griffiths CEM. (2001). A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. Journal of Investigative Dermatology, 116, 672-678. eScholarID:1d3063 | DOI:10.1046/j.1523-1747.2001.01322.x
  • Williams, TL, C May, Esmail, AB, Griffiths, CEM, N Shaw, Fitzgerald, D, Stewart, EJC, M Mould, M Morgan, L Pickup, S Kelly. (2001). Patient satisfaction with teledermatology is related to perceived quality of life. British Journal Of Dermatology, 145, 911-917. eScholarID:1d23691 | DOI:10.1046/j.1365-2133.2001.04472.x
  • Williams, TL, May,C., Esmail, AB, Ellis,N., Griffiths, CEM, Stewart, EJC, Fitzgerald, D, Morgan,M., Mould,M., Pickup,L., Kelly,S. (2001). Patient satisfaction with store-and-forward teledermatology. Journal of Telemedicine & Telecare, 7, Suppl 6, eScholarID:1d5864 | DOI:10.1258/1357633011936679

2000

  • Ashcroft DM, Li Wan Po A, Griffiths CEM. (2000). Therapeutic strategies for psoriasis. Journal of Clinical Pharmacy and Therapeutics, 25, 1-10. eScholarID:1d23350
  • Ashcroft DM, Li Wan Po A, Williams H.C, Griffiths CEM. (2000). Combination regimens of topical calcipotriol in chronic plaque psoriasis: A systematic review of their efficacy and tolerability. Archives Of Dermatology, 136, 1536-1543. eScholarID:1d23330
  • Ashcroft DM, Li Wan Po A, Williams H.C, Griffiths CEM. (2000). Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol in the treatment of mild-to-moderate plaque psoriasis. Pharmacoeconomics, 18[5], 469-476. eScholarID:1d23332
  • Ashcroft DM, Li Wan Po A, Williams H.C, Griffiths CEM. (2000). Systematic review of comparative efficacy and tolerability of calcipotriol in the treatment of chronic plaque psoriasis. British Medical Journal, 320, 963-967. eScholarID:1d23352
  • Bhushan M, Moore TL, Herrick AL, Griffiths CEM. (2000). Nailfold video capillaroscopy in psoriasis. Br J Dermatol, 142( 6), 1171-6. eScholarID:1d21806
  • DG Fortune, Richards HL, Main CJ, Griffiths CEM. (2000). Pathological worrying, illness perceptions and disease severity in patients with psoriasis. British Journal of Health Psychology, 5, 71-82. eScholarID:1d10844
  • Kirby B, Fortune D, Bhushan M, Chalmers RJG, Griffiths CEM. (2000). The Salford Psoriasis Index (SPI): an holistic measure of psoriasis severity. Br J Dermatol, 142, 728-732. eScholarID:1d2496
  • Harrison BJ, Herrick AL, Griffiths CEM. (2000). Psoriasis and diffuse systemic sclerosis: a report of three patients. Rheumatology, 39, 213-215. eScholarID:17d807

1999

  • Ashcroft DM, Li Wan Po A, Williams H.C, Griffiths CEM. (1999). Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. British Journal Of Dermatology, 141, 185-191. eScholarID:1d23356
  • Watson REB, Griffiths CEM, Craven N, Shuttleworth CC.A, Kielty CM. (1999). Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution at the dermal-epidermal junction. Journal of Investigative Dermatology, 112, 782-787. eScholarID:1d3061

1998

  • Ashcroft DM, Li Wan Po A, Williams H.C, Griffiths CEM. (1998). Quality of life measures in psoriasis: a critical appraisal of their quality. Journal of Clinical Pharmacy and Therapeutics, 23(5), 391-398. eScholarID:1d23358
  • DG Fortune, Richards HL, Main CJ, TM O'Sullivan, Griffiths CEM. (1998). Developing clinical psychology services in an outpatient dermatology specialist clinic. Clinical Psychology Forum, 115, 34-36. eScholarID:1d10846
  • Gilmour,E., Campbell, SM, Loane,M.A., Esmail, AB, Griffiths, CEM, Roland, M, Parry,E.J., Corbett,R.O., Eedy,D., Gore,H.E., Mathews,C., Steel,K., Wootton,R. (1998). Comparison of teleconsultations and face-to-face consultations: preliminary results of a United Kingdom multicentre teledermatology study. British Journal of Dermatology, 139, 1, eScholarID:1d22160

  • Griffiths CEM. Leukocyte extravasation as a target for anti-inflammatory therapies in dermatology: which molecular target is best? Exp Derm, eScholarID:1d8472
  • Griffiths, T. & Griffiths, C Cosmeceuticals. Skinmed, 10(5), 272-4. eScholarID:198858 | PMID:23163068